data_2ap8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ap8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 4.4 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 CA-C-O 120.764 0.235 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -84.21 -35.18 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.541 0.686 . . . . 0.0 109.287 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -58.85 -28.54 66.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.387 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.68 -37.64 29.87 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -74.33 -28.57 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.563 0.697 . . . . 0.0 110.124 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.06 -46.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.097 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.34 -20.86 75.6 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -43.81 37.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.13 -29.98 38.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.463 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.2 mt -67.67 -51.64 47.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.181 0.515 . . . . 0.0 110.549 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.9 -20.16 78.65 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.346 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.951 -179.522 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.455 -0.785 0 CA-C-O 120.683 0.201 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.17 -36.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.633 0.73 . . . . 0.0 109.306 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.96 -49.39 77.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.301 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.91 -22.72 77.13 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.086 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -38.13 55.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.881 0.848 . . . . 0.0 109.918 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.42 -46.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.276 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.14 -20.87 71.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.7 t -74.68 -43.38 55.48 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -28.36 32.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.729 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.22 -51.69 67.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.0 0.428 . . . . 0.0 110.63 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.48 -20.51 73.73 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.387 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.431 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 61.1 Cg_endo . . . . . 0 N--CA 1.454 -0.838 0 CA-C-O 120.641 0.184 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.99 -37.09 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 109.061 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -28.56 54.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.173 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -78.2 -39.08 24.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.849 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.94 -33.71 57.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 110.514 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.36 -50.24 20.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.39 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.93 -20.8 72.92 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -64.04 -51.1 65.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.84 -33.48 27.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.933 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.28 -52.02 15.5 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.101 0.477 . . . . 0.0 110.976 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.28 -19.7 79.72 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.875 -179.622 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.528 0.194 0 N-CA-C 113.192 0.42 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.8 -35.69 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.0 109.41 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tp -63.09 -49.41 74.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.418 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -70.04 -22.49 77.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.108 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -37.3 57.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.836 0.826 . . . . 0.0 109.9 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.26 -48.34 24.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.254 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -20.93 70.91 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER -69.9 -45.91 66.58 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -26.23 33.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.619 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.09 -51.76 68.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 110.575 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.97 -20.47 68.78 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.248 179.801 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 3.5 Cg_exo . . . . . 0 N--CA 1.458 -0.582 0 N-CA-C 112.708 0.234 . . . . 0.0 112.708 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.86 -39.67 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.719 0.771 . . . . 0.0 109.479 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.403 ' HA ' HD11 ' A' ' 6' ' ' LEU . 60.6 tp -63.49 -49.02 75.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.757 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -71.07 -22.34 78.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.129 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -76.67 -35.8 57.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 110.015 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.0 -47.6 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.143 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -22.05 70.88 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 2.7 m -79.54 -45.39 19.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 109.568 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.68 -31.29 61.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.691 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 10.4 tp -63.2 -51.64 65.48 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.275 0.56 . . . . 0.0 110.116 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.87 -19.44 70.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.377 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.862 -179.664 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.849 0 CA-C-O 120.799 0.25 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -83.92 -35.36 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.582 0.706 . . . . 0.0 109.253 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -49.08 79.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.098 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.64 -24.14 75.38 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.069 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.06 49.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.895 0.855 . . . . 0.0 109.883 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.63 -48.78 23.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.371 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.49 -20.92 68.3 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.6 t -65.11 -49.99 67.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.23 -24.81 34.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.579 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.5 -51.7 68.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.142 0.496 . . . . 0.0 110.665 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.66 -20.28 79.55 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.513 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.462 -0.346 0 CA-C-O 120.706 0.211 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.7 t -84.66 -37.44 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -49.41 77.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.983 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.0 -22.85 77.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.0 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' O ' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.36 -38.51 55.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.024 0.916 . . . . 0.0 109.468 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -76.95 -45.44 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.006 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -22.32 71.91 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 28.7 t -73.0 -46.68 50.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.36 -30.53 63.37 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.975 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.74 -51.48 64.71 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.93 -20.0 74.14 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.343 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.307 179.893 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.458 -0.561 0 N-CA-C 112.613 0.197 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -84.56 -38.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.663 0.744 . . . . 0.0 109.283 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.02 -49.08 79.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -69.79 -24.15 76.48 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.244 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.5 -36.38 57.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.952 0.882 . . . . 0.0 110.025 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -78.96 -47.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.628 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.26 -22.47 74.55 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 22.0 p -75.1 -42.31 56.84 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.05 -29.37 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.717 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.7 mt -70.53 -52.09 24.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.093 0.473 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.79 -19.59 78.82 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.934 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 62.5 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 CA-C-O 120.612 0.172 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 23.5 t -84.56 -37.54 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.664 0.745 . . . . 0.0 109.208 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.42 -28.71 60.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.447 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.24 -37.52 28.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.717 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -76.61 -32.68 58.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.443 0.639 . . . . 0.0 110.244 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.29 -50.29 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.169 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -20.94 70.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 t -66.9 -49.49 65.43 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.33 -28.92 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.714 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.8 -51.72 65.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.98 -20.73 76.47 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.214 179.794 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 N-CA-C 111.435 -0.256 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.2 t -84.57 -37.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 109.404 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -49.27 77.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.246 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.21 -22.96 77.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.118 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.07 -36.86 55.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.815 0.817 . . . . 0.0 110.19 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -47.26 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.194 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.28 -20.83 65.7 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.556 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -73.57 -43.64 59.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.27 -29.08 38.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.624 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.04 -51.98 40.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.17 0.51 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.59 -19.84 78.89 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.747 -179.718 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.942 0.309 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.11 -40.87 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.0 tp -56.48 -44.95 81.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.48 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.82 -29.2 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.985 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.11 -39.6 48.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.857 0.837 . . . . 0.0 110.155 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.19 -49.16 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.467 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.44 -20.79 65.99 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -46.44 65.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 -31.11 30.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.64 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.405 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 55.4 mt -71.34 -51.21 25.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.61 -20.49 56.29 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.248 179.909 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 N--CA 1.464 -0.211 0 CA-C-O 120.656 0.19 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.25 -37.46 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.684 0.754 . . . . 0.0 108.991 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.66 -48.77 79.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.491 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -70.53 -23.81 77.32 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.998 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.96 -38.08 53.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.966 0.889 . . . . 0.0 109.923 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.77 -47.68 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.271 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -62.34 -21.23 61.9 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 4.7 p -66.87 -48.22 69.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.21 -27.84 32.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.664 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -51.52 69.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.133 0.492 . . . . 0.0 110.805 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 -19.81 78.22 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.627 -179.904 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 N--CA 1.458 -0.604 0 N-CA-C 112.867 0.295 . . . . 0.0 112.867 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.0 t -85.47 -38.62 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.638 0.732 . . . . 0.0 109.531 179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.41 -49.46 77.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.59 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.94 -22.67 77.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.033 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -38.51 56.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.853 0.835 . . . . 0.0 109.846 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.01 -47.87 26.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.052 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.42 -20.9 70.08 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -71.25 -43.34 67.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.15 -31.18 30.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.503 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.79 -51.89 24.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.107 0.48 . . . . 0.0 110.533 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.33 79.35 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.626 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.462 -0.363 0 N-CA-C 112.465 0.14 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.2 t -84.81 -40.08 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.716 0.77 . . . . 0.0 109.477 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -49.26 76.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.4 -25.58 74.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.147 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -39.39 50.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.846 0.832 . . . . 0.0 110.083 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -50.35 20.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.65 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -63.45 -20.89 63.97 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.02 63.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -24.12 34.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.054 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.3 tp -56.86 -52.04 66.67 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.123 0.487 . . . . 0.0 110.82 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.42 -20.47 78.32 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.348 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.405 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 6.7 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.663 0.193 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 38.6 t -84.46 -37.73 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.711 0.767 . . . . 0.0 109.161 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 tp -55.94 -28.7 58.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.534 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.96 -35.49 30.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.832 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.62 -30.37 56.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.449 0.642 . . . . 0.0 110.482 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.02 -49.22 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.34 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.75 -20.89 74.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -78.51 -40.22 35.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 109.6 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.08 -31.26 30.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.677 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.85 -51.74 56.28 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.42 -20.12 79.21 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.773 -179.732 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.451 -0.975 0 CA-C-O 120.816 0.257 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -84.96 -39.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.672 0.749 . . . . 0.0 109.352 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -49.21 78.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.0 -24.29 75.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.153 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.92 -39.54 50.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.874 0.845 . . . . 0.0 109.969 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.31 -48.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.412 -179.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.02 -20.68 67.11 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -69.93 -48.21 59.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.47 34.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.841 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.59 -51.84 67.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.6 -19.92 78.8 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.689 -179.912 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.459 -0.516 0 CA-C-O 120.605 0.169 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -83.97 -40.72 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.846 0.831 . . . . 0.0 108.823 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 48.8 tp -53.58 -49.1 68.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.442 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.83 -25.93 74.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.125 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -38.61 52.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.827 0.823 . . . . 0.0 109.976 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.28 -49.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.414 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.51 -20.83 68.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.21 -49.6 63.94 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.26 -23.98 35.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.709 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.05 -51.99 64.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.145 0.498 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.56 78.09 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.549 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo . . . . . 0 CA--C 1.527 0.149 0 N-CA-C 112.651 0.212 . . . . 0.0 112.651 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.454 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 37.2 t -84.2 -36.0 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 109.136 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -58.13 -29.81 65.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.611 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -77.28 -32.4 48.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.794 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.38 -31.33 57.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.499 0.666 . . . . 0.0 110.169 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.13 -49.5 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.17 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.78 -21.26 76.48 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -64.55 -46.57 82.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.25 -28.16 32.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.418 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.64 -51.76 68.04 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.136 0.493 . . . . 0.0 110.604 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -20.5 73.91 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.499 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.462 -0.356 0 CA-C-O 120.663 0.193 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -84.47 -37.24 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.686 0.755 . . . . 0.0 109.21 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.27 -49.07 78.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.223 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.58 -25.25 75.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.047 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -39.97 48.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.824 0.821 . . . . 0.0 109.973 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.27 -49.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.446 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.71 -20.76 66.55 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.84 -49.14 63.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -25.12 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.731 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -56.77 -51.81 67.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.177 0.513 . . . . 0.0 110.704 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.33 -20.21 79.84 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.493 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.444 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 CA-C-O 120.674 0.197 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.22 -37.89 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.671 0.748 . . . . 0.0 109.052 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.14 -28.38 52.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.403 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -79.12 -37.83 24.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.78 -32.55 57.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.34 0.59 . . . . 0.0 110.424 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.43 -50.53 20.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.397 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.29 -20.88 71.75 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t -69.68 -46.42 66.09 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.5 -32.5 28.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.893 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.17 -52.19 15.06 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.05 -20.39 74.71 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.4 tt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.606 0.241 . . . . 0.0 111.464 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.24 -54.08 0.41 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.427 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 4.4 Cg_endo -85.71 -13.02 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.282 2.654 . . . . 0.0 111.774 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -84.21 -35.18 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.541 0.686 . . . . 0.0 109.287 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -58.85 -28.54 66.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.387 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.68 -37.64 29.87 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -74.33 -28.57 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.563 0.697 . . . . 0.0 110.124 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.06 -46.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.097 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.34 -20.86 75.6 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -43.81 37.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.13 -29.98 38.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.463 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 15.2 mt -67.67 -51.64 47.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.181 0.515 . . . . 0.0 110.549 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' A' ' 17' ' ' LEU . . . -71.9 -20.16 78.65 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.0 -58.96 11.82 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.951 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -18.33 59.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.268 0.556 . . . . 0.0 109.584 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.536 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -65.36 -56.36 13.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.443 ' HE2' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -83.55 -4.31 58.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.863 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.814 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.89 139.89 55.14 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.477 0.656 . . . . 0.0 112.159 -179.071 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.611 -179.062 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 2' ' ' DIL . 3.0 mp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.701 0.286 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.4 ' O ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.95 -62.8 0.56 Allowed Glycine 0 C--N 1.315 -0.63 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.952 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -84.31 -1.5 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.981 2.454 . . . . 0.0 112.181 178.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.17 -36.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.633 0.73 . . . . 0.0 109.306 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.96 -49.39 77.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.301 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.91 -22.72 77.13 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.086 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.53 -38.13 55.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.881 0.848 . . . . 0.0 109.918 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.42 -46.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.276 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.14 -20.87 71.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.7 t -74.68 -43.38 55.48 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -28.36 32.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.729 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.22 -51.69 67.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.0 0.428 . . . . 0.0 110.63 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.48 -20.51 73.73 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.13 -35.59 48.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.387 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.19 -28.56 54.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.248 0.547 . . . . 0.0 109.548 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -52.47 61.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -54.56 8.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.791 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.76 124.32 20.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.982 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.512 -179.43 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.66 0.266 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.08 -62.77 0.13 Allowed Glycine 0 C--N 1.312 -0.772 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 61.1 Cg_endo -85.3 -9.26 8.39 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.95 2.433 . . . . 0.0 111.97 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.99 -37.09 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 109.061 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -28.56 54.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.173 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -78.2 -39.08 24.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.849 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.94 -33.71 57.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 110.514 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.36 -50.24 20.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.39 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.93 -20.8 72.92 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -64.04 -51.1 65.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.84 -33.48 27.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.933 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.28 -52.02 15.5 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.101 0.477 . . . . 0.0 110.976 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.28 -19.7 79.72 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.44 -54.75 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.875 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -77.59 -28.13 51.55 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.116 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.49 -45.77 65.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.232 -179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.75 -0.59 54.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.109 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -25.97 67.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.727 ' N ' ' O ' ' A' ' 18' ' ' LYS . 1.8 mm . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.868 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 5.7 tp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.618 0.247 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.501 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.02 -107.67 1.16 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.377 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 2' ' ' DIL . 57.2 Cg_endo -69.24 -3.01 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.509 2.139 . . . . 0.0 113.192 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.8 -35.69 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.0 109.41 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tp -63.09 -49.41 74.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.418 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -70.04 -22.49 77.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.108 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.31 -37.3 57.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.836 0.826 . . . . 0.0 109.9 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.26 -48.34 24.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.254 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -20.93 70.91 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER -69.9 -45.91 66.58 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -26.23 33.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.619 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.09 -51.76 68.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 110.575 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.97 -20.47 68.78 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.01 -30.51 69.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.248 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp -77.1 -29.58 54.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.4 mt -63.62 -44.22 94.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.577 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.41 -34.27 75.71 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.792 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -64.51 135.0 55.59 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.546 0.688 . . . . 0.0 112.166 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.542 -179.072 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 16.7 tt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.568 0.223 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.44 ' O ' HG13 ' A' ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.425 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 88.88 -98.69 2.47 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.128 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 3.5 Cg_exo -79.82 -1.43 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.558 2.172 . . . . 0.0 112.708 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.86 -39.67 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.719 0.771 . . . . 0.0 109.479 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.403 ' HA ' HD11 ' A' ' 6' ' ' LEU . 60.6 tp -63.49 -49.02 75.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.757 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -71.07 -22.34 78.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.129 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' A' ' 4' ' ' PRO . 0.1 OUTLIER -76.67 -35.8 57.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 110.015 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.0 -47.6 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.143 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -22.05 70.88 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 2.7 m -79.54 -45.39 19.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 109.568 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.68 -31.29 61.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.691 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 10.4 tp -63.2 -51.64 65.48 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.275 0.56 . . . . 0.0 110.116 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.87 -19.44 70.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.95 -57.4 19.16 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.862 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.01 -28.34 54.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.263 0.554 . . . . 0.0 109.679 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.6 -49.91 75.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.745 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -45.92 65.77 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.791 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.51 136.02 57.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.495 0.664 . . . . 0.0 112.164 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.25 1.088 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.439 -179.242 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.575 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 5.0 tp . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.351 0.13 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.575 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.29 -59.62 0.01 OUTLIER Glycine 0 C--N 1.314 -0.673 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.533 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.34 -5.1 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.051 2.501 . . . . 0.0 111.505 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -83.92 -35.36 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.582 0.706 . . . . 0.0 109.253 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.45 -49.08 79.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.098 179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.422 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.64 -24.14 75.38 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.069 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.74 -40.06 49.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.895 0.855 . . . . 0.0 109.883 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.63 -48.78 23.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.371 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.49 -20.92 68.3 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.6 t -65.11 -49.99 67.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.23 -24.81 34.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.579 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.5 -51.7 68.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.142 0.496 . . . . 0.0 110.665 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.66 -20.28 79.55 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.5 57.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.21 -29.89 54.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -53.33 7.72 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.153 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.797 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.37 140.4 58.02 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.513 0.673 . . . . 0.0 112.172 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.2 mm . . . . . 0 C--O 1.249 1.035 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.641 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.605 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.605 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.78 -89.69 1.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.74 -6.85 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.591 2.194 . . . . 0.0 112.145 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.7 t -84.66 -37.44 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -49.41 77.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.983 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.0 -22.85 77.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.0 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' O ' HD11 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.36 -38.51 55.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.024 0.916 . . . . 0.0 109.468 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -76.95 -45.44 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.006 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -22.32 71.91 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 28.7 t -73.0 -46.68 50.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.36 -30.53 63.37 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.975 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.74 -51.48 64.71 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.93 -20.0 74.14 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.49 -25.44 75.27 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.307 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 tp -76.91 -28.36 55.28 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.98 -43.09 83.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -57.97 3.49 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.115 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.789 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.09 128.62 37.69 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.518 0.675 . . . . 0.0 112.075 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mm . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.459 -179.352 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.576 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 11.5 tt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 111.29 0.108 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.576 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 87.54 -95.89 2.12 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.018 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.423 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 2.0 Cg_endo -82.17 6.38 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.783 2.322 . . . . 0.0 112.613 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -84.56 -38.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.663 0.744 . . . . 0.0 109.283 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.02 -49.08 79.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -69.79 -24.15 76.48 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.244 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.5 -36.38 57.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.952 0.882 . . . . 0.0 110.025 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.45 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -78.96 -47.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.628 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.26 -22.47 74.55 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 22.0 p -75.1 -42.31 56.84 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.05 -29.37 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.717 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 26.7 mt -70.53 -52.09 24.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.093 0.473 . . . . 0.0 110.851 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.79 -19.59 78.82 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.86 -52.61 46.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.934 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.18 -26.55 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.098 0.475 . . . . 0.0 110.168 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -50.81 72.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.093 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -46.41 25.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.483 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.793 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.9 141.79 58.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.497 0.665 . . . . 0.0 112.273 -178.436 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.249 1.033 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.61 -178.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.58 -69.11 0.05 OUTLIER Glycine 0 C--N 1.311 -0.837 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.526 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.443 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 62.5 Cg_endo -85.8 -8.44 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.828 2.352 . . . . 0.0 111.994 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 23.5 t -84.56 -37.54 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.664 0.745 . . . . 0.0 109.208 178.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.42 -28.71 60.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.447 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.24 -37.52 28.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.717 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.2 OUTLIER -76.61 -32.68 58.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.443 0.639 . . . . 0.0 110.244 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.29 -50.29 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.169 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -20.94 70.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 t -66.9 -49.49 65.43 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.33 -28.92 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.714 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.8 -51.72 65.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.98 -20.73 76.47 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.78 -39.46 95.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.214 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -31.13 53.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -53.01 62.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -55.2 25.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.94 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.773 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -64.29 124.97 23.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.66 . . . . 0.0 111.911 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 mm . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 6.3 mt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.82 0.343 . . . . 0.0 111.389 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.75 -68.51 0.3 Allowed Glycine 0 C--N 1.311 -0.837 0 CA-C-N 114.15 -1.387 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.51 -3.31 10.71 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.111 2.54 . . . . 0.0 111.435 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.2 t -84.57 -37.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 109.404 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -49.27 77.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.246 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.21 -22.96 77.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.118 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.07 -36.86 55.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.815 0.817 . . . . 0.0 110.19 179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -47.26 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.194 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.28 -20.83 65.7 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.556 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -73.57 -43.64 59.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.27 -29.08 38.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.624 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.04 -51.98 40.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.17 0.51 . . . . 0.0 110.547 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.59 -19.84 78.89 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.61 -34.81 90.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.747 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.69 -34.27 52.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.272 0.558 . . . . 0.0 109.602 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 mt -69.89 -35.1 74.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.767 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -60.9 2.14 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.183 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.78 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.62 120.31 10.93 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.825 -178.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.506 -179.423 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 15.1 tt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.614 0.245 . . . . 0.0 111.552 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 89.62 -97.93 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.655 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 11.7 Cg_exo -69.75 -18.13 37.24 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.27 1.98 . . . . 0.0 111.757 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.11 -40.87 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.0 tp -56.48 -44.95 81.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.48 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.82 -29.2 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.985 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.11 -39.6 48.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.857 0.837 . . . . 0.0 110.155 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.19 -49.16 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.467 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.44 -20.79 65.99 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -46.44 65.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 -31.11 30.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.64 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.405 ' HB2' ' HA2' ' A' ' 10' ' ' GLY . 55.4 mt -71.34 -51.21 25.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.61 -20.49 56.29 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.97 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.248 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.41 -30.21 53.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.95 -37.25 70.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.676 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.712 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.84 -0.45 53.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.071 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.58 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -25.8 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -178.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.712 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.1 mm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.545 HG12 ' O ' ' A' ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.72 -103.57 1.77 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.035 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -71.84 -2.62 11.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.452 2.101 . . . . 0.0 112.416 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.6 t -84.25 -37.46 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.684 0.754 . . . . 0.0 108.991 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.66 -48.77 79.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.491 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.534 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -70.53 -23.81 77.32 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.998 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.96 -38.08 53.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.966 0.889 . . . . 0.0 109.923 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.77 -47.68 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.271 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -62.34 -21.23 61.9 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.534 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 4.7 p -66.87 -48.22 69.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.21 -27.84 32.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.664 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.7 -51.52 69.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.133 0.492 . . . . 0.0 110.805 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 -19.81 78.22 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.21 77.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.627 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 pp -77.29 -37.46 52.73 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.49 0.662 . . . . 0.0 109.587 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -54.16 -48.85 70.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.132 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.99 -35.56 62.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.285 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.799 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -66.74 140.5 57.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.519 0.676 . . . . 0.0 112.361 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.628 -178.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.644 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.644 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.39 -109.74 1.31 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.298 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.16 8.33 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.66 2.24 . . . . 0.0 112.867 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.42 HG23 ' CG1' ' A' ' 2' ' ' DIL . 74.0 t -85.47 -38.62 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.638 0.732 . . . . 0.0 109.531 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.41 -49.46 77.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.59 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.94 -22.67 77.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.033 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.19 -38.51 56.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.853 0.835 . . . . 0.0 109.846 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.46 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.01 -47.87 26.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.052 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.42 -20.9 70.08 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -71.25 -43.34 67.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.15 -31.18 30.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.503 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 70.1 mt -70.79 -51.89 24.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.107 0.48 . . . . 0.0 110.533 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.33 79.35 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.16 92.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.626 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tt -77.16 -29.02 54.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.189 0.519 . . . . 0.0 109.633 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.47 -54.89 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.55 -56.2 9.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.77 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.99 124.27 20.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.604 -179.331 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 19.5 tt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.569 0.223 . . . . 0.0 111.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.498 HG12 ' O ' ' A' ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 79.43 -102.05 1.93 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.0 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 4.7 Cg_exo -77.14 -0.18 10.34 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.596 2.197 . . . . 0.0 112.465 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.2 t -84.81 -40.08 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.716 0.77 . . . . 0.0 109.477 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -49.26 76.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.4 -25.58 74.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.147 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.05 -39.39 50.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.846 0.832 . . . . 0.0 110.083 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -50.35 20.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.65 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -63.45 -20.89 63.97 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.02 63.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -24.12 34.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.054 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.3 tp -56.86 -52.04 66.67 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.123 0.487 . . . . 0.0 110.82 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.42 -20.47 78.32 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.78 -28.94 73.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.348 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.71 54.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -45.27 80.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.691 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -40.54 71.31 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.785 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -66.75 136.06 54.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.414 0.625 . . . . 0.0 112.127 -178.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.544 -179.225 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 2' ' ' DIL . 6.6 tp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.793 0.33 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.401 ' N ' HG22 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.29 -101.5 2.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.597 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 6.7 Cg_exo -72.46 -8.6 22.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.311 2.007 . . . . 0.0 111.922 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 38.6 t -84.46 -37.73 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.711 0.767 . . . . 0.0 109.161 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 tp -55.94 -28.7 58.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.534 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.96 -35.49 30.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.832 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.448 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.62 -30.37 56.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.449 0.642 . . . . 0.0 110.482 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.02 -49.22 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.34 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.75 -20.89 74.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -78.51 -40.22 35.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 109.6 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.08 -31.26 30.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.677 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -65.85 -51.74 56.28 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.42 -20.12 79.21 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -46.23 94.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.773 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.5 -32.51 54.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.543 . . . . 0.0 109.609 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.94 -44.41 80.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.708 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -56.9 8.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.22 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.794 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.2 126.82 28.66 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.47 0.652 . . . . 0.0 112.045 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.7 mm . . . . . 0 C--O 1.248 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.474 -179.387 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.668 0.27 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.23 -62.03 0.01 OUTLIER Glycine 0 C--N 1.311 -0.839 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.708 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -84.57 -11.56 8.06 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.199 2.599 . . . . 0.0 111.641 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -84.96 -39.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.672 0.749 . . . . 0.0 109.352 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -49.21 78.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.0 -24.29 75.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.153 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.92 -39.54 50.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.874 0.845 . . . . 0.0 109.969 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.31 -48.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.412 -179.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.02 -20.68 67.11 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -69.93 -48.21 59.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.47 34.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.841 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.59 -51.84 67.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.6 -19.92 78.8 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.49 -18.46 79.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.689 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 -32.23 55.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.96 -40.85 75.16 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.82 -18.1 60.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.797 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -69.9 142.88 52.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.501 0.667 . . . . 0.0 112.304 -178.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.609 -179.014 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.416 HG23 HD11 ' A' ' 1' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.748 0.309 . . . . 0.0 111.232 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.497 HG12 ' O ' ' A' ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 92.68 -91.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.883 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 3.1 Cg_exo -79.88 2.21 8.6 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.718 2.279 . . . . 0.0 112.172 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -83.97 -40.72 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.846 0.831 . . . . 0.0 108.823 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 48.8 tp -53.58 -49.1 68.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.442 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.83 -25.93 74.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.125 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.0 -38.61 52.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.827 0.823 . . . . 0.0 109.976 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.28 -49.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.414 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.51 -20.83 68.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.21 -49.6 63.94 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.26 -23.98 35.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.709 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.05 -51.99 64.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.145 0.498 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.56 78.09 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.94 78.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.549 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -77.04 -31.68 56.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.02 -36.64 82.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.62 3.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.078 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.781 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.08 129.93 42.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.45 0.643 . . . . 0.0 112.033 -178.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.528 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' A' ' 2' ' ' DIL . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 52.86 -104.47 0.19 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.56 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 18.5 Cg_exo -65.86 -8.33 19.4 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 37.2 t -84.2 -36.0 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 109.136 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -58.13 -29.81 65.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.611 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -77.28 -32.4 48.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.794 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.454 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.38 -31.33 57.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.499 0.666 . . . . 0.0 110.169 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.13 -49.5 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.17 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.78 -21.26 76.48 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -64.55 -46.57 82.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.25 -28.16 32.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.418 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 tt -60.64 -51.76 68.04 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.136 0.493 . . . . 0.0 110.604 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -20.5 73.91 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.81 63.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -29.56 53.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.55 -50.89 71.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.714 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.413 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -75.63 -56.09 5.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.883 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.779 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.3 137.82 58.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.43 0.633 . . . . 0.0 111.927 -178.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.583 -178.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.416 ' O ' ' CG1' ' A' ' 2' ' ' DIL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 85.03 -99.08 2.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.921 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 2.6 Cg_exo -75.41 -3.7 14.27 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.509 2.139 . . . . 0.0 112.206 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -84.47 -37.24 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.686 0.755 . . . . 0.0 109.21 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.27 -49.07 78.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.223 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.58 -25.25 75.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.047 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.98 -39.97 48.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.824 0.821 . . . . 0.0 109.973 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.27 -49.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.446 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.71 -20.76 66.55 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.84 -49.14 63.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -25.12 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.731 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -56.77 -51.81 67.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.177 0.513 . . . . 0.0 110.704 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.33 -20.21 79.84 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.86 -38.54 75.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.29 -29.25 53.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.268 0.556 . . . . 0.0 109.679 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -55.9 22.48 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -53.37 35.19 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.779 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.75 126.24 26.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.454 0.645 . . . . 0.0 112.017 -178.673 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.535 -179.489 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.413 HG21 ' N ' ' A' ' 2' ' ' DIL . 2.5 tt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' DIL . . . . . 0.413 ' N ' HG21 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.93 -67.18 0.36 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 113.886 -1.507 . . . . 0.0 110.948 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo -83.07 -10.78 10.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.077 2.518 . . . . 0.0 111.704 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.22 -37.89 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.671 0.748 . . . . 0.0 109.052 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.14 -28.38 52.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.403 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -79.12 -37.83 24.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.78 -32.55 57.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.34 0.59 . . . . 0.0 110.424 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.465 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.43 -50.53 20.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.397 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.29 -20.88 71.75 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t -69.68 -46.42 66.09 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.5 -32.5 28.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.893 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.17 -52.19 15.06 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.05 -20.39 74.71 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.55 -56.65 20.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -77.58 -26.02 50.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.007 0.432 . . . . 0.0 109.99 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -70.82 -43.12 69.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.016 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.754 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.54 -1.08 55.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.072 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.586 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -26.64 65.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -179.015 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.754 ' N ' ' O ' ' A' ' 18' ' ' LYS . 1.1 mm . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.847 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 4.4 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 CA-C-O 120.764 0.235 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -84.21 -35.18 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.541 0.686 . . . . 0.0 109.287 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -58.85 -28.54 66.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.387 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.68 -37.64 29.87 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -74.33 -28.57 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.563 0.697 . . . . 0.0 110.124 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.06 -46.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.097 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.34 -20.86 75.6 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -43.81 37.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.13 -29.98 38.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.463 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.2 mt -67.67 -51.64 47.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.181 0.515 . . . . 0.0 110.549 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.9 -20.16 78.65 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.346 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.951 -179.522 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.455 -0.785 0 CA-C-O 120.683 0.201 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.17 -36.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.633 0.73 . . . . 0.0 109.306 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.96 -49.39 77.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.301 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.91 -22.72 77.13 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.086 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.53 -38.13 55.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.881 0.848 . . . . 0.0 109.918 179.536 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.42 -46.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.276 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.14 -20.87 71.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.7 t -74.68 -43.38 55.48 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -28.36 32.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.729 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.22 -51.69 67.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.0 0.428 . . . . 0.0 110.63 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.48 -20.51 73.73 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.387 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.439 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 61.1 Cg_endo . . . . . 0 N--CA 1.454 -0.838 0 CA-C-O 120.641 0.184 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.99 -37.09 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 109.061 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -28.56 54.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.173 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -78.2 -39.08 24.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.849 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.94 -33.71 57.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 110.514 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.36 -50.24 20.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.39 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.93 -20.8 72.92 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -64.04 -51.1 65.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.84 -33.48 27.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.933 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.28 -52.02 15.5 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.101 0.477 . . . . 0.0 110.976 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.28 -19.7 79.72 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.875 -179.622 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.528 0.194 0 N-CA-C 113.192 0.42 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.8 -35.69 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.0 109.41 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tp -63.09 -49.41 74.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.418 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -70.04 -22.49 77.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.108 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.31 -37.3 57.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.836 0.826 . . . . 0.0 109.9 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.26 -48.34 24.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.254 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -20.93 70.91 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER -69.9 -45.91 66.58 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -26.23 33.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.619 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.09 -51.76 68.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 110.575 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.97 -20.47 68.78 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.248 179.801 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 3.5 Cg_exo . . . . . 0 N--CA 1.458 -0.582 0 N-CA-C 112.708 0.234 . . . . 0.0 112.708 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.86 -39.67 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.719 0.771 . . . . 0.0 109.479 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.49 -49.02 75.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -71.07 -22.34 78.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.129 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.67 -35.8 57.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 110.015 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.0 -47.6 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.143 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -22.05 70.88 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 2.7 m -79.54 -45.39 19.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 109.568 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.68 -31.29 61.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.691 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 10.4 tp -63.2 -51.64 65.48 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.275 0.56 . . . . 0.0 110.116 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.87 -19.44 70.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.377 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.862 -179.664 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.849 0 CA-C-O 120.799 0.25 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -83.92 -35.36 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.582 0.706 . . . . 0.0 109.253 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -60.45 -49.08 79.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.098 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.563 ' N ' HD23 ' A' ' 6' ' ' LEU . . . -68.64 -24.14 75.38 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.069 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.637 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.74 -40.06 49.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.895 0.855 . . . . 0.0 109.883 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.63 -48.78 23.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.371 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.49 -20.92 68.3 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.6 t -65.11 -49.99 67.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.23 -24.81 34.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.579 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.5 -51.7 68.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.142 0.496 . . . . 0.0 110.665 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.66 -20.28 79.55 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.513 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.462 -0.346 0 CA-C-O 120.706 0.211 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 8' ' ' LEU . 36.7 t -84.66 -37.44 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -49.41 77.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.983 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.0 -22.85 77.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.0 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -76.36 -38.51 55.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.024 0.916 . . . . 0.0 109.468 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -76.95 -45.44 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.006 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -22.32 71.91 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 28.7 t -73.0 -46.68 50.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.36 -30.53 63.37 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.975 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.74 -51.48 64.71 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.93 -20.0 74.14 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.343 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.307 179.893 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.458 -0.561 0 N-CA-C 112.613 0.197 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -84.56 -38.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.663 0.744 . . . . 0.0 109.283 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.02 -49.08 79.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.79 -24.15 76.48 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.244 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.706 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.5 -36.38 57.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.952 0.882 . . . . 0.0 110.025 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.685 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -78.96 -47.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.628 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.26 -22.47 74.55 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 22.0 p -75.1 -42.31 56.84 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.05 -29.37 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.717 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.685 HD12 HG13 ' A' ' 9' ' ' VAL . 26.7 mt -70.53 -52.09 24.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.093 0.473 . . . . 0.0 110.851 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.79 -19.59 78.82 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.934 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 62.5 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 CA-C-O 120.612 0.172 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.56 -37.54 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.664 0.745 . . . . 0.0 109.208 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.42 -28.71 60.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.447 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.24 -37.52 28.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.717 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -76.61 -32.68 58.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.443 0.639 . . . . 0.0 110.244 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.29 -50.29 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.169 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -20.94 70.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 t -66.9 -49.49 65.43 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.33 -28.92 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.714 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 17.7 tp -62.8 -51.72 65.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 110.612 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.98 -20.73 76.47 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.214 179.794 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 N-CA-C 111.435 -0.256 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 8' ' ' LEU . 40.2 t -84.57 -37.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 109.404 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -49.27 77.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.246 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.21 -22.96 77.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.118 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.07 -36.86 55.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.815 0.817 . . . . 0.0 110.19 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -47.26 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.194 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.28 -20.83 65.7 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.558 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -73.57 -43.64 59.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.27 -29.08 38.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.624 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -68.04 -51.98 40.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.17 0.51 . . . . 0.0 110.547 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.59 -19.84 78.89 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.747 -179.718 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.942 0.309 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.11 -40.87 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.0 tp -56.48 -44.95 81.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.48 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.82 -29.2 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.985 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.11 -39.6 48.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.857 0.837 . . . . 0.0 110.155 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.748 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.19 -49.16 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.467 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.44 -20.79 65.99 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -46.44 65.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 -31.11 30.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.64 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.748 HD12 HG13 ' A' ' 9' ' ' VAL . 55.4 mt -71.34 -51.21 25.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.61 -20.49 56.29 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.248 179.909 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 N--CA 1.464 -0.211 0 CA-C-O 120.656 0.19 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 8' ' ' LEU . 47.6 t -84.25 -37.46 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.684 0.754 . . . . 0.0 108.991 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.66 -48.77 79.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.491 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -70.53 -23.81 77.32 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.998 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.96 -38.08 53.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.966 0.889 . . . . 0.0 109.923 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.77 -47.68 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.271 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -62.34 -21.23 61.9 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 4.7 p -66.87 -48.22 69.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.21 -27.84 32.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.664 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -59.7 -51.52 69.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.133 0.492 . . . . 0.0 110.805 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 -19.81 78.22 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.627 -179.904 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 N--CA 1.458 -0.604 0 N-CA-C 112.867 0.295 . . . . 0.0 112.867 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HA ' HD23 ' A' ' 8' ' ' LEU . 74.0 t -85.47 -38.62 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.638 0.732 . . . . 0.0 109.531 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.41 -49.46 77.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.59 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.94 -22.67 77.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.033 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.65 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.19 -38.51 56.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.853 0.835 . . . . 0.0 109.846 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.585 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.01 -47.87 26.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.052 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.42 -20.9 70.08 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -71.25 -43.34 67.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.15 -31.18 30.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.503 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.585 HD12 HG13 ' A' ' 9' ' ' VAL . 70.1 mt -70.79 -51.89 24.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.107 0.48 . . . . 0.0 110.533 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.33 79.35 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.626 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.462 -0.363 0 N-CA-C 112.465 0.14 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.2 t -84.81 -40.08 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.716 0.77 . . . . 0.0 109.477 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -49.26 76.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.4 -25.58 74.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.147 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.636 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.05 -39.39 50.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.846 0.832 . . . . 0.0 110.083 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -50.35 20.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.65 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -63.45 -20.89 63.97 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.02 63.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -24.12 34.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.054 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.3 tp -56.86 -52.04 66.67 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.123 0.487 . . . . 0.0 110.82 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.42 -20.47 78.32 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.348 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 6.7 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.663 0.193 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 38.6 t -84.46 -37.73 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.711 0.767 . . . . 0.0 109.161 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 tp -55.94 -28.7 58.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.534 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.96 -35.49 30.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.832 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.62 -30.37 56.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.449 0.642 . . . . 0.0 110.482 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.757 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.02 -49.22 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.34 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.75 -20.89 74.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -78.51 -40.22 35.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 109.6 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.08 -31.26 30.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.677 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 9' ' ' VAL . 3.5 mm? -65.85 -51.74 56.28 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.42 -20.12 79.21 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.773 -179.732 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.451 -0.975 0 CA-C-O 120.816 0.257 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -84.96 -39.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.672 0.749 . . . . 0.0 109.352 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -49.21 78.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.0 -24.29 75.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.153 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.92 -39.54 50.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.874 0.845 . . . . 0.0 109.969 179.486 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.31 -48.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.412 -179.481 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.02 -20.68 67.11 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -69.93 -48.21 59.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.47 34.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.841 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.59 -51.84 67.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.6 -19.92 78.8 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.689 -179.912 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.459 -0.516 0 CA-C-O 120.605 0.169 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -83.97 -40.72 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.846 0.831 . . . . 0.0 108.823 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 48.8 tp -53.58 -49.1 68.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.442 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.83 -25.93 74.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.125 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.0 -38.61 52.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.827 0.823 . . . . 0.0 109.976 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.28 -49.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.414 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.51 -20.83 68.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.21 -49.6 63.94 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.26 -23.98 35.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.709 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.05 -51.99 64.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.145 0.498 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.56 78.09 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.549 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.417 ' O ' HD21 ' A' ' 8' ' ' LEU . 18.5 Cg_exo . . . . . 0 CA--C 1.527 0.149 0 N-CA-C 112.651 0.212 . . . . 0.0 112.651 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 37.2 t -84.2 -36.0 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 109.136 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -58.13 -29.81 65.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.611 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -77.28 -32.4 48.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.794 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.38 -31.33 57.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.499 0.666 . . . . 0.0 110.169 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.13 -49.5 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.17 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.78 -21.26 76.48 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -64.55 -46.57 82.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.25 -28.16 32.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.418 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 13' ' ' LEU . 4.2 tt -60.64 -51.76 68.04 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.136 0.493 . . . . 0.0 110.604 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -20.5 73.91 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.499 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.462 -0.356 0 CA-C-O 120.663 0.193 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -84.47 -37.24 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.686 0.755 . . . . 0.0 109.21 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.27 -49.07 78.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.223 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.58 -25.25 75.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.047 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.98 -39.97 48.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.824 0.821 . . . . 0.0 109.973 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.27 -49.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.446 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.71 -20.76 66.55 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.84 -49.14 63.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -25.12 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.731 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -56.77 -51.81 67.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.177 0.513 . . . . 0.0 110.704 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.33 -20.21 79.84 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.493 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.451 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 CA-C-O 120.674 0.197 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.22 -37.89 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.671 0.748 . . . . 0.0 109.052 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.14 -28.38 52.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.403 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -79.12 -37.83 24.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.78 -32.55 57.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.34 0.59 . . . . 0.0 110.424 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.68 ' O ' HD13 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.43 -50.53 20.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.397 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.29 -20.88 71.75 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t -69.68 -46.42 66.09 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.5 -32.5 28.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.893 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 9' ' ' VAL . 10.1 mp -73.17 -52.19 15.06 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.05 -20.39 74.71 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.906 HG23 HG23 ' A' ' 2' ' ' DIL . 15.4 tt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.606 0.241 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.906 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.24 -54.08 0.41 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 4.4 Cg_endo -85.71 -13.02 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.282 2.654 . . . . 0.0 111.774 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG23 HD12 ' A' ' 2' ' ' DIL . 46.2 t -84.21 -35.18 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.541 0.686 . . . . 0.0 109.287 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -58.85 -28.54 66.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.387 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.68 -37.64 29.87 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -74.33 -28.57 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.563 0.697 . . . . 0.0 110.124 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.06 -46.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.097 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.34 -20.86 75.6 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -43.81 37.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.13 -29.98 38.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.463 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.2 mt -67.67 -51.64 47.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.181 0.515 . . . . 0.0 110.549 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 17' ' ' LEU . . . -71.9 -20.16 78.65 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.0 -58.96 11.82 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.951 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -18.33 59.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.268 0.556 . . . . 0.0 109.584 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.558 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -65.36 -56.36 13.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HE2' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -83.55 -4.31 58.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.863 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.845 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.89 139.89 55.14 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.477 0.656 . . . . 0.0 112.159 -179.071 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.611 -179.062 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 2' ' ' DIL . 3.0 mp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.701 0.286 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.729 HG12 HG22 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.95 -62.8 0.56 Allowed Glycine 0 C--N 1.315 -0.63 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.952 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.414 ' HD2' ' CG2' ' A' ' 2' ' ' DIL . 63.8 Cg_endo -84.31 -1.5 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.981 2.454 . . . . 0.0 112.181 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.17 -36.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.633 0.73 . . . . 0.0 109.306 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.96 -49.39 77.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.301 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.91 -22.72 77.13 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.086 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.53 -38.13 55.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.881 0.848 . . . . 0.0 109.918 179.536 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.42 -46.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.276 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.14 -20.87 71.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.7 t -74.68 -43.38 55.48 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -28.36 32.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.729 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.22 -51.69 67.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.0 0.428 . . . . 0.0 110.63 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.48 -20.51 73.73 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.13 -35.59 48.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.387 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.19 -28.56 54.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.248 0.547 . . . . 0.0 109.548 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -52.47 61.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HE2' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.03 -54.56 8.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.162 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.821 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.76 124.32 20.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.982 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.512 -179.43 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.701 HG23 HG23 ' A' ' 2' ' ' DIL . 8.1 tp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.66 0.266 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.701 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.08 -62.77 0.13 Allowed Glycine 0 C--N 1.312 -0.772 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 61.1 Cg_endo -85.3 -9.26 8.39 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.95 2.433 . . . . 0.0 111.97 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.99 -37.09 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 109.061 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -28.56 54.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.173 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -78.2 -39.08 24.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.849 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.94 -33.71 57.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 110.514 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.36 -50.24 20.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.39 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.93 -20.8 72.92 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -64.04 -51.1 65.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.84 -33.48 27.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.933 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.477 ' O ' HD23 ' A' ' 17' ' ' LEU . 10.9 tp -73.28 -52.02 15.5 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.101 0.477 . . . . 0.0 110.976 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.28 -19.7 79.72 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.44 -54.75 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.875 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -77.59 -28.13 51.55 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.116 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 13' ' ' LEU . 3.6 mm? -70.49 -45.77 65.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.232 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.75 -0.59 54.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.109 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -25.97 67.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.727 ' N ' ' O ' ' A' ' 18' ' ' LYS . 1.8 mm . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.868 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.665 HG23 HG23 ' A' ' 2' ' ' DIL . 5.7 tp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.618 0.247 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.665 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.02 -107.67 1.16 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.377 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 2' ' ' DIL . 57.2 Cg_endo -69.24 -3.01 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.509 2.139 . . . . 0.0 113.192 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 2' ' ' DIL . 41.2 t -84.8 -35.69 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.0 109.41 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tp -63.09 -49.41 74.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.418 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -70.04 -22.49 77.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.108 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.31 -37.3 57.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.836 0.826 . . . . 0.0 109.9 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.26 -48.34 24.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.254 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -20.93 70.91 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER -69.9 -45.91 66.58 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -26.23 33.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.619 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.09 -51.76 68.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 110.575 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.97 -20.47 68.78 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.01 -30.51 69.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.248 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp -77.1 -29.58 54.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 17' ' ' LEU . 5.4 mt -63.62 -44.22 94.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.577 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.41 -34.27 75.71 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.823 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -64.51 135.0 55.59 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.546 0.688 . . . . 0.0 112.166 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.438 ' OXT' HG22 ' A' ' 20' ' ' ILE . 1.5 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.542 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 2' ' ' DIL . 16.7 tt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.568 0.223 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.992 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 88.88 -98.69 2.47 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.128 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 3.5 Cg_exo -79.82 -1.43 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.558 2.172 . . . . 0.0 112.708 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.86 -39.67 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.719 0.771 . . . . 0.0 109.479 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.49 -49.02 75.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -71.07 -22.34 78.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.129 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.67 -35.8 57.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 110.015 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.0 -47.6 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.143 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -22.05 70.88 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 2.7 m -79.54 -45.39 19.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 109.568 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.68 -31.29 61.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.691 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 10.4 tp -63.2 -51.64 65.48 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.275 0.56 . . . . 0.0 110.116 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.87 -19.44 70.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.95 -57.4 19.16 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.862 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.01 -28.34 54.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.263 0.554 . . . . 0.0 109.679 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.6 -49.91 75.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.745 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -45.92 65.77 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.817 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.51 136.02 57.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.495 0.664 . . . . 0.0 112.164 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.57 ' OXT' HG22 ' A' ' 20' ' ' ILE . 1.3 mp . . . . . 0 C--O 1.25 1.088 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.439 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.557 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 5.0 tp . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.351 0.13 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.557 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.29 -59.62 0.01 OUTLIER Glycine 0 C--N 1.314 -0.673 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.533 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.34 -5.1 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.051 2.501 . . . . 0.0 111.505 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -83.92 -35.36 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.582 0.706 . . . . 0.0 109.253 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -60.45 -49.08 79.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.098 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.563 ' N ' HD23 ' A' ' 6' ' ' LEU . . . -68.64 -24.14 75.38 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.069 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.637 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.74 -40.06 49.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.895 0.855 . . . . 0.0 109.883 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.63 -48.78 23.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.371 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.49 -20.92 68.3 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.6 t -65.11 -49.99 67.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.23 -24.81 34.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.579 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.5 -51.7 68.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.142 0.496 . . . . 0.0 110.665 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.66 -20.28 79.55 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.5 57.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -77.21 -29.89 54.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -53.33 7.72 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.153 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.827 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.37 140.4 58.02 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.513 0.673 . . . . 0.0 112.172 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.2 mm . . . . . 0 C--O 1.249 1.035 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.641 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.583 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.583 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.78 -89.69 1.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.74 -6.85 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.591 2.194 . . . . 0.0 112.145 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 8' ' ' LEU . 36.7 t -84.66 -37.44 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -49.41 77.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.983 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.0 -22.85 77.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.0 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -76.36 -38.51 55.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.024 0.916 . . . . 0.0 109.468 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -76.95 -45.44 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.006 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -22.32 71.91 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 28.7 t -73.0 -46.68 50.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.36 -30.53 63.37 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.975 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.74 -51.48 64.71 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.93 -20.0 74.14 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.49 -25.44 75.27 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.307 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 tp -76.91 -28.36 55.28 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.98 -43.09 83.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -57.97 3.49 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.115 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.817 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.09 128.62 37.69 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.518 0.675 . . . . 0.0 112.075 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mm . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.459 -179.352 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 11.5 tt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 111.29 0.108 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.554 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 87.54 -95.89 2.12 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.018 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 2.0 Cg_endo -82.17 6.38 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.783 2.322 . . . . 0.0 112.613 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -84.56 -38.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.663 0.744 . . . . 0.0 109.283 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.02 -49.08 79.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.79 -24.15 76.48 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.244 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.706 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.5 -36.38 57.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.952 0.882 . . . . 0.0 110.025 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.685 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -78.96 -47.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.628 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.26 -22.47 74.55 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 22.0 p -75.1 -42.31 56.84 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.05 -29.37 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.717 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.685 HD12 HG13 ' A' ' 9' ' ' VAL . 26.7 mt -70.53 -52.09 24.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.093 0.473 . . . . 0.0 110.851 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.79 -19.59 78.82 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.86 -52.61 46.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.934 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.18 -26.55 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.098 0.475 . . . . 0.0 110.168 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -50.81 72.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.093 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -46.41 25.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.483 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.819 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.9 141.79 58.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.497 0.665 . . . . 0.0 112.273 -178.436 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.249 1.033 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.61 -178.964 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.929 HG23 HG23 ' A' ' 2' ' ' DIL . 8.9 tp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.929 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.58 -69.11 0.05 OUTLIER Glycine 0 C--N 1.311 -0.837 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.526 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 62.5 Cg_endo -85.8 -8.44 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.828 2.352 . . . . 0.0 111.994 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.56 -37.54 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.664 0.745 . . . . 0.0 109.208 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.42 -28.71 60.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.447 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.24 -37.52 28.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.717 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -76.61 -32.68 58.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.443 0.639 . . . . 0.0 110.244 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.29 -50.29 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.169 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -20.94 70.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 t -66.9 -49.49 65.43 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.33 -28.92 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.714 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 17.7 tp -62.8 -51.72 65.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 110.612 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.98 -20.73 76.47 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.78 -39.46 95.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.214 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -31.13 53.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -53.01 62.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -55.2 25.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.94 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.802 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -64.29 124.97 23.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.66 . . . . 0.0 111.911 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 mm . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 1.026 HG22 HG23 ' A' ' 2' ' ' DIL . 6.3 mt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.82 0.343 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 1.026 HG23 HG22 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.75 -68.51 0.3 Allowed Glycine 0 C--N 1.311 -0.837 0 CA-C-N 114.15 -1.387 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.51 -3.31 10.71 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.111 2.54 . . . . 0.0 111.435 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 8' ' ' LEU . 40.2 t -84.57 -37.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 109.404 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -49.27 77.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.246 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.21 -22.96 77.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.118 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.07 -36.86 55.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.815 0.817 . . . . 0.0 110.19 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -47.26 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.194 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.28 -20.83 65.7 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.558 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -73.57 -43.64 59.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.27 -29.08 38.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.624 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -68.04 -51.98 40.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.17 0.51 . . . . 0.0 110.547 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.59 -19.84 78.89 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.61 -34.81 90.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.747 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.69 -34.27 52.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.272 0.558 . . . . 0.0 109.602 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 mt -69.89 -35.1 74.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.767 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -60.9 2.14 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.183 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.81 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.62 120.31 10.93 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.825 -178.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.506 -179.423 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.833 HG23 HG23 ' A' ' 2' ' ' DIL . 15.1 tt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.614 0.245 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.833 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 89.62 -97.93 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.655 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 11.7 Cg_exo -69.75 -18.13 37.24 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.27 1.98 . . . . 0.0 111.757 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.11 -40.87 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.0 tp -56.48 -44.95 81.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.48 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.82 -29.2 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.985 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.11 -39.6 48.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.857 0.837 . . . . 0.0 110.155 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.748 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.19 -49.16 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.467 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.44 -20.79 65.99 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -46.44 65.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 -31.11 30.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.64 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.748 HD12 HG13 ' A' ' 9' ' ' VAL . 55.4 mt -71.34 -51.21 25.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.61 -20.49 56.29 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.97 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.248 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.41 -30.21 53.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.95 -37.25 70.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.676 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.712 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.84 -0.45 53.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.071 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.581 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -25.8 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -178.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.712 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.1 mm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.975 HG22 HG23 ' A' ' 2' ' ' DIL . 3.1 mp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.975 HG23 HG22 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.72 -103.57 1.77 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.035 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 2' ' ' DIL . 8.8 Cg_exo -71.84 -2.62 11.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.452 2.101 . . . . 0.0 112.416 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG21 HG13 ' A' ' 2' ' ' DIL . 47.6 t -84.25 -37.46 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.684 0.754 . . . . 0.0 108.991 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.66 -48.77 79.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.491 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -70.53 -23.81 77.32 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.998 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.96 -38.08 53.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.966 0.889 . . . . 0.0 109.923 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.77 -47.68 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.271 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -62.34 -21.23 61.9 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 4.7 p -66.87 -48.22 69.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.21 -27.84 32.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.664 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -59.7 -51.52 69.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.133 0.492 . . . . 0.0 110.805 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 -19.81 78.22 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.21 77.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.627 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 13' ' ' LEU . 1.8 pp -77.29 -37.46 52.73 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.49 0.662 . . . . 0.0 109.587 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -54.16 -48.85 70.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.132 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.99 -35.56 62.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.285 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.828 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -66.74 140.5 57.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.519 0.676 . . . . 0.0 112.361 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.628 -178.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.625 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.625 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.39 -109.74 1.31 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.298 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.16 8.33 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.66 2.24 . . . . 0.0 112.867 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HA ' HD23 ' A' ' 8' ' ' LEU . 74.0 t -85.47 -38.62 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.638 0.732 . . . . 0.0 109.531 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.41 -49.46 77.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.59 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.94 -22.67 77.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.033 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.65 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.19 -38.51 56.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.853 0.835 . . . . 0.0 109.846 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.585 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.01 -47.87 26.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.052 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.42 -20.9 70.08 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -71.25 -43.34 67.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.15 -31.18 30.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.503 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.585 HD12 HG13 ' A' ' 9' ' ' VAL . 70.1 mt -70.79 -51.89 24.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.107 0.48 . . . . 0.0 110.533 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.33 79.35 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.16 92.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.626 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tt -77.16 -29.02 54.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.189 0.519 . . . . 0.0 109.633 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.47 -54.89 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.55 -56.2 9.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.798 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.99 124.27 20.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.604 -179.331 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.935 HG23 HG23 ' A' ' 2' ' ' DIL . 19.5 tt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.569 0.223 . . . . 0.0 111.504 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.935 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 79.43 -102.05 1.93 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.0 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 4.7 Cg_exo -77.14 -0.18 10.34 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.596 2.197 . . . . 0.0 112.465 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG21 HG13 ' A' ' 2' ' ' DIL . 40.2 t -84.81 -40.08 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.716 0.77 . . . . 0.0 109.477 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -49.26 76.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.4 -25.58 74.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.147 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.636 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.05 -39.39 50.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.846 0.832 . . . . 0.0 110.083 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -50.35 20.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.65 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -63.45 -20.89 63.97 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.02 63.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -24.12 34.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.054 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.3 tp -56.86 -52.04 66.67 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.123 0.487 . . . . 0.0 110.82 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.42 -20.47 78.32 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.78 -28.94 73.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.348 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.71 54.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -45.27 80.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.691 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -40.54 71.31 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.812 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -66.75 136.06 54.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.414 0.625 . . . . 0.0 112.127 -178.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.544 -179.225 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.754 HG23 HG23 ' A' ' 2' ' ' DIL . 6.6 tp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.793 0.33 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.754 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.29 -101.5 2.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.597 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 6.7 Cg_exo -72.46 -8.6 22.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.311 2.007 . . . . 0.0 111.922 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 38.6 t -84.46 -37.73 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.711 0.767 . . . . 0.0 109.161 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 tp -55.94 -28.7 58.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.534 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.96 -35.49 30.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.832 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.62 -30.37 56.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.449 0.642 . . . . 0.0 110.482 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.757 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.02 -49.22 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.34 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.75 -20.89 74.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -78.51 -40.22 35.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 109.6 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.08 -31.26 30.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.677 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 9' ' ' VAL . 3.5 mm? -65.85 -51.74 56.28 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.42 -20.12 79.21 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -46.23 94.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.773 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.5 -32.51 54.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.543 . . . . 0.0 109.609 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.94 -44.41 80.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.708 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -56.9 8.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.22 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.823 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.2 126.82 28.66 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.47 0.652 . . . . 0.0 112.045 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 20' ' ' ILE . 6.7 mm . . . . . 0 C--O 1.248 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.474 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 2' ' ' DIL . 7.7 tp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.668 0.27 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.874 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.23 -62.03 0.01 OUTLIER Glycine 0 C--N 1.311 -0.839 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.708 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -84.57 -11.56 8.06 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.199 2.599 . . . . 0.0 111.641 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -84.96 -39.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.672 0.749 . . . . 0.0 109.352 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -49.21 78.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.0 -24.29 75.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.153 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.92 -39.54 50.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.874 0.845 . . . . 0.0 109.969 179.486 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.31 -48.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.412 -179.481 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.02 -20.68 67.11 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -69.93 -48.21 59.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.47 34.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.841 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.59 -51.84 67.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.6 -19.92 78.8 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.49 -18.46 79.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.689 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 -32.23 55.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.96 -40.85 75.16 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HE2' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -74.82 -18.1 60.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.826 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -69.9 142.88 52.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.501 0.667 . . . . 0.0 112.304 -178.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.609 -179.014 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.948 HG23 HG23 ' A' ' 2' ' ' DIL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.748 0.309 . . . . 0.0 111.232 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.948 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 92.68 -91.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.883 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 3.1 Cg_exo -79.88 2.21 8.6 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.718 2.279 . . . . 0.0 112.172 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -83.97 -40.72 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.846 0.831 . . . . 0.0 108.823 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 48.8 tp -53.58 -49.1 68.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.442 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.83 -25.93 74.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.125 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.0 -38.61 52.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.827 0.823 . . . . 0.0 109.976 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.28 -49.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.414 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.51 -20.83 68.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.21 -49.6 63.94 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.26 -23.98 35.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.709 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.05 -51.99 64.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.145 0.498 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.56 78.09 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.94 78.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.549 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -77.04 -31.68 56.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.02 -36.64 82.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.62 3.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.078 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.808 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.08 129.93 42.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.45 0.643 . . . . 0.0 112.033 -178.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.528 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 1' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 52.86 -104.47 0.19 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.56 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.417 ' O ' HD21 ' A' ' 8' ' ' LEU . 18.5 Cg_exo -65.86 -8.33 19.4 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 37.2 t -84.2 -36.0 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 109.136 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -58.13 -29.81 65.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.611 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -77.28 -32.4 48.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.794 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.38 -31.33 57.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.499 0.666 . . . . 0.0 110.169 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.13 -49.5 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.17 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.78 -21.26 76.48 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -64.55 -46.57 82.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.25 -28.16 32.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.418 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 13' ' ' LEU . 4.2 tt -60.64 -51.76 68.04 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.136 0.493 . . . . 0.0 110.604 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -20.5 73.91 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.81 63.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -29.56 53.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.55 -50.89 71.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.714 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.413 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -75.63 -56.09 5.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.883 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.81 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.3 137.82 58.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.43 0.633 . . . . 0.0 111.927 -178.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.583 -178.965 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.922 HG23 HG23 ' A' ' 2' ' ' DIL . 6.1 tp . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.922 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 85.03 -99.08 2.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.921 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 2.6 Cg_exo -75.41 -3.7 14.27 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.509 2.139 . . . . 0.0 112.206 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -84.47 -37.24 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.686 0.755 . . . . 0.0 109.21 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.27 -49.07 78.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.223 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.58 -25.25 75.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.047 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.98 -39.97 48.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.824 0.821 . . . . 0.0 109.973 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.27 -49.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.446 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.71 -20.76 66.55 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.84 -49.14 63.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -25.12 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.731 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -56.77 -51.81 67.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.177 0.513 . . . . 0.0 110.704 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.33 -20.21 79.84 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.86 -38.54 75.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.29 -29.25 53.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.268 0.556 . . . . 0.0 109.679 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -55.9 22.48 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -53.37 35.19 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.808 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.75 126.24 26.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.454 0.645 . . . . 0.0 112.017 -178.673 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.535 -179.489 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.564 HG23 HG12 ' A' ' 2' ' ' DIL . 2.5 tt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' DIL . . . . . 0.564 HG12 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.93 -67.18 0.36 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 113.886 -1.507 . . . . 0.0 110.948 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo -83.07 -10.78 10.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.077 2.518 . . . . 0.0 111.704 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.22 -37.89 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.671 0.748 . . . . 0.0 109.052 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.14 -28.38 52.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.403 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -79.12 -37.83 24.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.78 -32.55 57.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.34 0.59 . . . . 0.0 110.424 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.68 ' O ' HD13 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.43 -50.53 20.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.397 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.29 -20.88 71.75 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t -69.68 -46.42 66.09 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.5 -32.5 28.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.893 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 9' ' ' VAL . 10.1 mp -73.17 -52.19 15.06 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.05 -20.39 74.71 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.55 -56.65 20.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -77.58 -26.02 50.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.007 0.432 . . . . 0.0 109.99 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.5 tm? -70.82 -43.12 69.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.016 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.754 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.54 -1.08 55.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.072 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -26.64 65.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -179.015 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.754 ' N ' ' O ' ' A' ' 18' ' ' LYS . 1.1 mm . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.847 179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 4.4 Cg_endo . . . . . 0 N--CA 1.452 -0.93 0 CA-C-O 120.764 0.235 . . . . 0.0 111.774 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -84.21 -35.18 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.541 0.686 . . . . 0.0 109.287 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -58.85 -28.54 66.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.387 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.68 -37.64 29.87 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -74.33 -28.57 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.563 0.697 . . . . 0.0 110.124 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.06 -46.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.097 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.34 -20.86 75.6 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -43.81 37.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.13 -29.98 38.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.463 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.2 mt -67.67 -51.64 47.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.181 0.515 . . . . 0.0 110.549 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.9 -20.16 78.65 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.346 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.951 -179.522 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 N--CA 1.455 -0.785 0 CA-C-O 120.683 0.201 . . . . 0.0 112.181 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.17 -36.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.633 0.73 . . . . 0.0 109.306 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.96 -49.39 77.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.301 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.91 -22.72 77.13 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.086 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.53 -38.13 55.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.881 0.848 . . . . 0.0 109.918 179.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.42 -46.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.276 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.14 -20.87 71.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.7 t -74.68 -43.38 55.48 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -28.36 32.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.729 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.22 -51.69 67.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.0 0.428 . . . . 0.0 110.63 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.48 -20.51 73.73 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.387 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.439 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 61.1 Cg_endo . . . . . 0 N--CA 1.454 -0.838 0 CA-C-O 120.641 0.184 . . . . 0.0 111.97 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.99 -37.09 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 109.061 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -28.56 54.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.173 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -78.2 -39.08 24.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.849 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.94 -33.71 57.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 110.514 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.36 -50.24 20.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.39 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.93 -20.8 72.92 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -64.04 -51.1 65.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.84 -33.48 27.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.933 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.28 -52.02 15.5 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.101 0.477 . . . . 0.0 110.976 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.28 -19.7 79.72 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.875 -179.622 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.528 0.194 0 N-CA-C 113.192 0.42 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -84.8 -35.69 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.0 109.41 179.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tp -63.09 -49.41 74.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.418 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -70.04 -22.49 77.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.108 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.31 -37.3 57.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.836 0.826 . . . . 0.0 109.9 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.26 -48.34 24.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.254 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -20.93 70.91 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER -69.9 -45.91 66.58 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -26.23 33.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.619 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.09 -51.76 68.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 110.575 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.97 -20.47 68.78 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.248 179.801 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 3.5 Cg_exo . . . . . 0 N--CA 1.458 -0.582 0 N-CA-C 112.708 0.234 . . . . 0.0 112.708 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.86 -39.67 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.719 0.771 . . . . 0.0 109.479 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.49 -49.02 75.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -71.07 -22.34 78.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.129 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.67 -35.8 57.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 110.015 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.0 -47.6 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.143 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -22.05 70.88 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 2.7 m -79.54 -45.39 19.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 109.568 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.68 -31.29 61.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.691 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 10.4 tp -63.2 -51.64 65.48 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.275 0.56 . . . . 0.0 110.116 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.87 -19.44 70.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.377 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.862 -179.664 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.849 0 CA-C-O 120.799 0.25 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -83.92 -35.36 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.582 0.706 . . . . 0.0 109.253 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -60.45 -49.08 79.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.098 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.563 ' N ' HD23 ' A' ' 6' ' ' LEU . . . -68.64 -24.14 75.38 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.069 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.637 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.74 -40.06 49.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.895 0.855 . . . . 0.0 109.883 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.63 -48.78 23.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.371 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.49 -20.92 68.3 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.6 t -65.11 -49.99 67.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.23 -24.81 34.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.579 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.5 -51.7 68.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.142 0.496 . . . . 0.0 110.665 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.66 -20.28 79.55 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.513 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo . . . . . 0 N--CA 1.462 -0.346 0 CA-C-O 120.706 0.211 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 8' ' ' LEU . 36.7 t -84.66 -37.44 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -49.41 77.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.983 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.0 -22.85 77.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.0 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -76.36 -38.51 55.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.024 0.916 . . . . 0.0 109.468 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -76.95 -45.44 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.006 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -22.32 71.91 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 28.7 t -73.0 -46.68 50.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.36 -30.53 63.37 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.975 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.74 -51.48 64.71 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.93 -20.0 74.14 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.343 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.307 179.893 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.458 -0.561 0 N-CA-C 112.613 0.197 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -84.56 -38.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.663 0.744 . . . . 0.0 109.283 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.02 -49.08 79.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.79 -24.15 76.48 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.244 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.706 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.5 -36.38 57.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.952 0.882 . . . . 0.0 110.025 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.685 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -78.96 -47.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.628 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.26 -22.47 74.55 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 22.0 p -75.1 -42.31 56.84 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.05 -29.37 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.717 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.685 HD12 HG13 ' A' ' 9' ' ' VAL . 26.7 mt -70.53 -52.09 24.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.093 0.473 . . . . 0.0 110.851 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.79 -19.59 78.82 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.934 -179.565 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.45 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 62.5 Cg_endo . . . . . 0 N--CA 1.453 -0.902 0 CA-C-O 120.612 0.172 . . . . 0.0 111.994 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.56 -37.54 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.664 0.745 . . . . 0.0 109.208 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.42 -28.71 60.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.447 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.24 -37.52 28.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.717 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -76.61 -32.68 58.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.443 0.639 . . . . 0.0 110.244 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.29 -50.29 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.169 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -20.94 70.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 t -66.9 -49.49 65.43 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.33 -28.92 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.714 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 17.7 tp -62.8 -51.72 65.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 110.612 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.98 -20.73 76.47 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.214 179.794 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo . . . . . 0 N--CA 1.453 -0.874 0 N-CA-C 111.435 -0.256 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 8' ' ' LEU . 40.2 t -84.57 -37.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 109.404 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -49.27 77.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.246 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.21 -22.96 77.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.118 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.07 -36.86 55.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.815 0.817 . . . . 0.0 110.19 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -47.26 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.194 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.28 -20.83 65.7 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.558 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -73.57 -43.64 59.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.27 -29.08 38.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.624 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -68.04 -51.98 40.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.17 0.51 . . . . 0.0 110.547 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.59 -19.84 78.89 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.747 -179.718 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo . . . . . 0 N--CA 1.461 -0.39 0 CA-C-O 120.942 0.309 . . . . 0.0 111.757 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.11 -40.87 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.0 tp -56.48 -44.95 81.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.48 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.82 -29.2 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.985 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.11 -39.6 48.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.857 0.837 . . . . 0.0 110.155 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.748 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.19 -49.16 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.467 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.44 -20.79 65.99 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -46.44 65.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 -31.11 30.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.64 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.748 HD12 HG13 ' A' ' 9' ' ' VAL . 55.4 mt -71.34 -51.21 25.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.61 -20.49 56.29 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.248 179.909 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo . . . . . 0 N--CA 1.464 -0.211 0 CA-C-O 120.656 0.19 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' HA ' HD23 ' A' ' 8' ' ' LEU . 47.6 t -84.25 -37.46 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.684 0.754 . . . . 0.0 108.991 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.66 -48.77 79.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.491 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -70.53 -23.81 77.32 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.998 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.96 -38.08 53.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.966 0.889 . . . . 0.0 109.923 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.77 -47.68 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.271 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -62.34 -21.23 61.9 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 4.7 p -66.87 -48.22 69.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.21 -27.84 32.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.664 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -59.7 -51.52 69.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.133 0.492 . . . . 0.0 110.805 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 -19.81 78.22 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.627 -179.904 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 N--CA 1.458 -0.604 0 N-CA-C 112.867 0.295 . . . . 0.0 112.867 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HA ' HD23 ' A' ' 8' ' ' LEU . 74.0 t -85.47 -38.62 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.638 0.732 . . . . 0.0 109.531 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.41 -49.46 77.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.59 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.94 -22.67 77.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.033 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.65 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.19 -38.51 56.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.853 0.835 . . . . 0.0 109.846 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.585 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.01 -47.87 26.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.052 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.42 -20.9 70.08 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -71.25 -43.34 67.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.15 -31.18 30.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.503 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.585 HD12 HG13 ' A' ' 9' ' ' VAL . 70.1 mt -70.79 -51.89 24.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.107 0.48 . . . . 0.0 110.533 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.33 79.35 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.626 -179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo . . . . . 0 N--CA 1.462 -0.363 0 N-CA-C 112.465 0.14 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.2 t -84.81 -40.08 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.716 0.77 . . . . 0.0 109.477 179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -49.26 76.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.4 -25.58 74.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.147 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.636 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.05 -39.39 50.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.846 0.832 . . . . 0.0 110.083 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -50.35 20.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.65 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -63.45 -20.89 63.97 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.02 63.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -24.12 34.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.054 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.3 tp -56.86 -52.04 66.67 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.123 0.487 . . . . 0.0 110.82 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.42 -20.47 78.32 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.348 179.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 6.7 Cg_exo . . . . . 0 N--CA 1.462 -0.377 0 CA-C-O 120.663 0.193 . . . . 0.0 111.922 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 38.6 t -84.46 -37.73 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.711 0.767 . . . . 0.0 109.161 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 tp -55.94 -28.7 58.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.534 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.96 -35.49 30.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.832 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.62 -30.37 56.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.449 0.642 . . . . 0.0 110.482 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.757 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.02 -49.22 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.34 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.75 -20.89 74.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -78.51 -40.22 35.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 109.6 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.08 -31.26 30.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.677 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 9' ' ' VAL . 3.5 mm? -65.85 -51.74 56.28 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.42 -20.12 79.21 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.773 -179.732 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo . . . . . 0 N--CA 1.451 -0.975 0 CA-C-O 120.816 0.257 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -84.96 -39.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.672 0.749 . . . . 0.0 109.352 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -49.21 78.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.0 -24.29 75.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.153 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.92 -39.54 50.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.874 0.845 . . . . 0.0 109.969 179.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.31 -48.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.412 -179.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.02 -20.68 67.11 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -69.93 -48.21 59.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.47 34.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.841 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.59 -51.84 67.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.6 -19.92 78.8 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.689 -179.912 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo . . . . . 0 N--CA 1.459 -0.516 0 CA-C-O 120.605 0.169 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -83.97 -40.72 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.846 0.831 . . . . 0.0 108.823 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 48.8 tp -53.58 -49.1 68.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.442 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.83 -25.93 74.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.125 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.0 -38.61 52.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.827 0.823 . . . . 0.0 109.976 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.28 -49.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.414 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.51 -20.83 68.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.21 -49.6 63.94 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.26 -23.98 35.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.709 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.05 -51.99 64.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.145 0.498 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.56 78.09 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.549 179.934 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.417 ' O ' HD21 ' A' ' 8' ' ' LEU . 18.5 Cg_exo . . . . . 0 CA--C 1.527 0.149 0 N-CA-C 112.651 0.212 . . . . 0.0 112.651 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 37.2 t -84.2 -36.0 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 109.136 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -58.13 -29.81 65.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.611 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -77.28 -32.4 48.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.794 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.38 -31.33 57.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.499 0.666 . . . . 0.0 110.169 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.13 -49.5 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.17 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.78 -21.26 76.48 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -64.55 -46.57 82.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.25 -28.16 32.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.418 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 13' ' ' LEU . 4.2 tt -60.64 -51.76 68.04 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.136 0.493 . . . . 0.0 110.604 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -20.5 73.91 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.499 -179.944 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo . . . . . 0 N--CA 1.462 -0.356 0 CA-C-O 120.663 0.193 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -84.47 -37.24 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.686 0.755 . . . . 0.0 109.21 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.27 -49.07 78.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.223 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.58 -25.25 75.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.047 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.98 -39.97 48.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.824 0.821 . . . . 0.0 109.973 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.27 -49.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.446 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.71 -20.76 66.55 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.84 -49.14 63.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -25.12 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.731 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -56.77 -51.81 67.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.177 0.513 . . . . 0.0 110.704 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.33 -20.21 79.84 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.493 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.451 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 CA-C-O 120.674 0.197 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.22 -37.89 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.671 0.748 . . . . 0.0 109.052 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.14 -28.38 52.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.403 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -79.12 -37.83 24.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.78 -32.55 57.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.34 0.59 . . . . 0.0 110.424 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.68 ' O ' HD13 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.43 -50.53 20.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.397 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.29 -20.88 71.75 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t -69.68 -46.42 66.09 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.5 -32.5 28.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.893 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 9' ' ' VAL . 10.1 mp -73.17 -52.19 15.06 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.05 -20.39 74.71 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.899 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.906 HG23 HG23 ' A' ' 2' ' ' DIL . 15.4 tt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.606 0.241 . . . . 0.0 111.464 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.906 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 156.24 -54.08 0.41 Allowed Glycine 0 C--N 1.313 -0.749 0 CA-C-N 114.392 -1.277 . . . . 0.0 110.826 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.436 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 4.4 Cg_endo -85.71 -13.02 6.05 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 123.282 2.654 . . . . 0.0 111.774 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.496 HG23 HD12 ' A' ' 2' ' ' DIL . 46.2 t -84.21 -35.18 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 121.541 0.686 . . . . 0.0 109.287 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 tp -58.85 -28.54 66.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.387 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.68 -37.64 29.87 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.055 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.4 OUTLIER -74.33 -28.57 61.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.563 0.697 . . . . 0.0 110.124 179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.06 -46.39 29.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.097 -179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.438 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.34 -20.86 75.6 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 177.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -76.52 -43.81 37.77 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.13 -29.98 38.95 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.463 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 13' ' ' LEU . 15.2 mt -67.67 -51.64 47.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.181 0.515 . . . . 0.0 110.549 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.558 ' HA2' ' HB2' ' A' ' 17' ' ' LEU . . . -71.9 -20.16 78.65 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.0 -58.96 11.82 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.951 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.98 -18.33 59.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.268 0.556 . . . . 0.0 109.584 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.558 ' HB2' ' HA2' ' A' ' 14' ' ' GLY . 0.9 OUTLIER -65.36 -56.36 13.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.309 -0.859 . . . . 0.0 111.111 -179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' HE2' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -83.55 -4.31 58.44 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.863 -179.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.845 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -68.89 139.89 55.14 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 121.477 0.656 . . . . 0.0 112.159 -179.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp . . . . . 0 C--O 1.25 1.107 0 CA-C-N 114.88 -1.054 . . . . 0.0 111.611 -179.062 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.729 HG22 HG12 ' A' ' 2' ' ' DIL . 3.0 mp . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.701 0.286 . . . . 0.0 110.974 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.729 HG12 HG22 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.95 -62.8 0.56 Allowed Glycine 0 C--N 1.315 -0.63 0 CA-C-N 113.799 -1.546 . . . . 0.0 110.952 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.414 ' HD2' ' CG2' ' A' ' 2' ' ' DIL . 63.8 Cg_endo -84.31 -1.5 9.78 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 122.981 2.454 . . . . 0.0 112.181 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.5 t -84.17 -36.27 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 CA-C-O 121.633 0.73 . . . . 0.0 109.306 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.96 -49.39 77.66 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.301 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.91 -22.72 77.13 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.086 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.677 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.53 -38.13 55.61 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.881 0.848 . . . . 0.0 109.918 179.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.42 -46.88 27.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.276 -179.666 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.14 -20.87 71.44 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 177.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.433 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.7 t -74.68 -43.38 55.48 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -28.36 32.34 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.729 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 18.4 mt -61.22 -51.69 67.91 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.0 0.428 . . . . 0.0 110.63 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.48 -20.51 73.73 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.13 -35.59 48.65 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.035 -0.602 . . . . 0.0 112.387 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -77.19 -28.56 54.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.248 0.547 . . . . 0.0 109.548 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.32 -52.47 61.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.758 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.405 ' HE2' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -73.03 -54.56 8.25 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.162 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.821 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.76 124.32 20.72 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.982 -178.745 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.1 mm . . . . . 0 C--O 1.249 1.03 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.512 -179.43 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.701 HG23 HG23 ' A' ' 2' ' ' DIL . 8.1 tp . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 120.66 0.266 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.701 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 173.08 -62.77 0.13 Allowed Glycine 0 C--N 1.312 -0.772 0 CA-C-N 114.198 -1.365 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.439 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 61.1 Cg_endo -85.3 -9.26 8.39 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.95 2.433 . . . . 0.0 111.97 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -83.99 -37.09 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 CA-C-O 121.649 0.738 . . . . 0.0 109.061 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.36 -28.56 54.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.173 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -78.2 -39.08 24.18 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.849 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.94 -33.71 57.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.352 0.596 . . . . 0.0 110.514 179.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.36 -50.24 20.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.39 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.93 -20.8 72.92 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 177.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -64.04 -51.1 65.78 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.84 -33.48 27.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.933 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.477 ' O ' HD23 ' A' ' 17' ' ' LEU . 10.9 tp -73.28 -52.02 15.5 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.101 0.477 . . . . 0.0 110.976 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.28 -19.7 79.72 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -57.44 -54.75 34.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.875 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -77.59 -28.13 51.55 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.116 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 13' ' ' LEU . 3.6 mm? -70.49 -45.77 65.0 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.232 -179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.727 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.75 -0.59 54.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.109 -179.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.572 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -25.97 67.13 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -178.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.727 ' N ' ' O ' ' A' ' 18' ' ' LYS . 1.8 mm . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.868 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.665 HG23 HG23 ' A' ' 2' ' ' DIL . 5.7 tp . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.618 0.247 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.665 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 58.02 -107.67 1.16 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.377 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 2' ' ' DIL . 57.2 Cg_endo -69.24 -3.01 10.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.509 2.139 . . . . 0.0 113.192 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 2' ' ' DIL . 41.2 t -84.8 -35.69 10.49 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 CA-C-O 121.618 0.723 . . . . 0.0 109.41 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 tp -63.09 -49.41 74.58 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.418 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -70.04 -22.49 77.23 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.108 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.31 -37.3 57.62 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.836 0.826 . . . . 0.0 109.9 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.449 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.26 -48.34 24.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.254 -179.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.449 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -20.93 70.91 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.6 OUTLIER -69.9 -45.91 66.58 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.09 -26.23 33.79 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.619 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.3 tp -57.09 -51.76 68.01 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 121.068 0.461 . . . . 0.0 110.575 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.97 -20.47 68.78 Favored Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 110.677 -0.969 . . . . 0.0 110.677 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.01 -30.51 69.93 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.248 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.3 tp -77.1 -29.58 54.96 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 17' ' ' LEU . 5.4 mt -63.62 -44.22 94.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.577 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.428 ' HE3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.41 -34.27 75.71 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.146 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.823 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -64.51 135.0 55.59 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.546 0.688 . . . . 0.0 112.166 -178.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.438 ' OXT' HG22 ' A' ' 20' ' ' ILE . 1.5 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.542 -179.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.992 HG23 HG23 ' A' ' 2' ' ' DIL . 16.7 tt . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.568 0.223 . . . . 0.0 111.427 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.992 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 88.88 -98.69 2.47 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.128 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.489 ' O ' ' HB3' ' A' ' 8' ' ' LEU . 3.5 Cg_exo -79.82 -1.43 11.43 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.558 2.172 . . . . 0.0 112.708 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -85.86 -39.67 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.719 0.771 . . . . 0.0 109.479 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.49 -49.02 75.23 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.451 -1.249 . . . . 0.0 110.757 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -71.07 -22.34 78.46 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.129 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.765 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.67 -35.8 57.7 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.792 0.806 . . . . 0.0 110.015 179.536 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.0 -47.6 26.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 114.339 -1.3 . . . . 0.0 109.143 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -22.05 70.88 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 2.7 m -79.54 -45.39 19.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.249 0.547 . . . . 0.0 109.568 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.68 -31.29 61.86 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.691 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 10.4 tp -63.2 -51.64 65.48 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.275 0.56 . . . . 0.0 110.116 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.87 -19.44 70.32 Favored Glycine 0 N--CA 1.445 -0.725 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 177.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.95 -57.4 19.16 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.862 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 9.2 tp -77.01 -28.34 54.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.263 0.554 . . . . 0.0 109.679 179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.6 tp -60.6 -49.91 75.65 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.745 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.15 -45.92 65.77 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.114 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.817 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.51 136.02 57.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.495 0.664 . . . . 0.0 112.164 -178.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.57 ' OXT' HG22 ' A' ' 20' ' ' ILE . 1.3 mp . . . . . 0 C--O 1.25 1.088 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.439 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.557 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 5.0 tp . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 111.351 0.13 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.557 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -158.29 -59.62 0.01 OUTLIER Glycine 0 C--N 1.314 -0.673 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.533 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -82.34 -5.1 11.85 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.051 2.501 . . . . 0.0 111.505 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.5 t -83.92 -35.36 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.308 0 CA-C-O 121.582 0.706 . . . . 0.0 109.253 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.563 HD23 ' N ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -60.45 -49.08 79.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.665 -1.152 . . . . 0.0 110.098 179.132 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.563 ' N ' HD23 ' A' ' 6' ' ' LEU . . . -68.64 -24.14 75.38 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.069 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.637 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.74 -40.06 49.71 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.895 0.855 . . . . 0.0 109.883 179.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.63 -48.78 23.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.079 -1.419 . . . . 0.0 109.371 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.453 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.49 -20.92 68.3 Favored Glycine 0 N--CA 1.44 -1.039 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.422 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 1.6 t -65.11 -49.99 67.83 Favored 'General case' 0 CA--C 1.521 -0.166 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.23 -24.81 34.65 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.579 178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -57.5 -51.7 68.37 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.142 0.496 . . . . 0.0 110.665 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.66 -20.28 79.55 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.4 -25.5 57.92 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.513 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.429 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -77.21 -29.89 54.44 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 80.1 mt -68.08 -40.69 82.65 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.58 -53.33 7.72 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.153 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.827 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -61.37 140.4 58.02 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 121.513 0.673 . . . . 0.0 112.172 -178.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.2 mm . . . . . 0 C--O 1.249 1.035 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.641 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.583 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 111.317 0.117 . . . . 0.0 111.317 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.583 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 95.78 -89.69 1.16 Allowed Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -71.74 -6.85 19.99 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.591 2.194 . . . . 0.0 112.145 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.541 ' HA ' HD23 ' A' ' 8' ' ' LEU . 36.7 t -84.66 -37.44 12.58 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.83 -49.41 77.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.983 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.0 -22.85 77.28 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.0 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -76.36 -38.51 55.72 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 122.024 0.916 . . . . 0.0 109.468 179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -76.95 -45.44 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.913 -1.494 . . . . 0.0 109.006 179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.83 -22.32 71.91 Favored Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 28.7 t -73.0 -46.68 50.78 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.36 -30.53 63.37 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.975 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 12.1 tp -63.74 -51.48 64.71 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.241 0.543 . . . . 0.0 110.043 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -77.93 -20.0 74.14 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.49 -25.44 75.27 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.307 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 20.7 tp -76.91 -28.36 55.28 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -66.98 -43.09 83.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.267 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.52 -57.97 3.49 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.115 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.817 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -60.09 128.62 37.69 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.518 0.675 . . . . 0.0 112.075 -178.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mm . . . . . 0 C--O 1.249 1.053 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.459 -179.352 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.554 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 11.5 tt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 111.29 0.108 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.554 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.433 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 87.54 -95.89 2.12 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.018 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.433 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 2.0 Cg_endo -82.17 6.38 5.75 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.783 2.322 . . . . 0.0 112.613 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.7 t -84.56 -38.35 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-O 121.663 0.744 . . . . 0.0 109.283 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -59.02 -49.08 79.25 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.437 -1.256 . . . . 0.0 110.585 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.79 -24.15 76.48 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.244 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.706 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.5 -36.38 57.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.952 0.882 . . . . 0.0 110.025 179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.685 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -78.96 -47.26 23.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.11 -1.404 . . . . 0.0 109.628 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.26 -22.47 74.55 Favored Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 178.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 22.0 p -75.1 -42.31 56.84 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.05 -29.37 31.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.717 179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.685 HD12 HG13 ' A' ' 9' ' ' VAL . 26.7 mt -70.53 -52.09 24.2 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-O 121.093 0.473 . . . . 0.0 110.851 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.79 -19.59 78.82 Favored Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.86 -52.61 46.92 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.934 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.2 mt -77.18 -26.55 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.098 0.475 . . . . 0.0 110.168 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.92 -50.81 72.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.093 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.7 -46.41 25.7 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.483 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.819 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.9 141.79 58.55 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.497 0.665 . . . . 0.0 112.273 -178.436 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.249 1.033 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.61 -178.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.929 HG23 HG23 ' A' ' 2' ' ' DIL . 8.9 tp . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.717 0.294 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.929 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.58 -69.11 0.05 OUTLIER Glycine 0 C--N 1.311 -0.837 0 CA-C-N 114.158 -1.383 . . . . 0.0 110.526 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.45 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 62.5 Cg_endo -85.8 -8.44 8.1 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 122.828 2.352 . . . . 0.0 111.994 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.56 -37.54 12.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.356 0 CA-C-O 121.664 0.745 . . . . 0.0 109.208 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 tp -56.42 -28.71 60.2 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 114.476 -1.238 . . . . 0.0 110.447 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.24 -37.52 28.09 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.717 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -76.61 -32.68 58.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.443 0.639 . . . . 0.0 110.244 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.29 -50.29 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.169 179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.38 -20.94 70.03 Favored Glycine 0 N--CA 1.441 -0.972 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 177.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 t -66.9 -49.49 65.43 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.33 -28.92 31.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.714 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 17.7 tp -62.8 -51.72 65.98 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.083 0.468 . . . . 0.0 110.612 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.98 -20.73 76.47 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.699 -0.961 . . . . 0.0 110.699 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.78 -39.46 95.18 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.214 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.52 -31.13 53.24 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.74 -53.01 62.6 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.571 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -55.2 25.5 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.94 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.802 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -64.29 124.97 23.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 121.485 0.66 . . . . 0.0 111.911 -178.66 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.2 mm . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.469 -179.429 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 1.026 HG22 HG23 ' A' ' 2' ' ' DIL . 6.3 mt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 120.82 0.343 . . . . 0.0 111.389 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 1.026 HG23 HG22 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 154.75 -68.51 0.3 Allowed Glycine 0 C--N 1.311 -0.837 0 CA-C-N 114.15 -1.387 . . . . 0.0 110.426 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.51 -3.31 10.71 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.111 2.54 . . . . 0.0 111.435 178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 8' ' ' LEU . 40.2 t -84.57 -37.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.626 0.727 . . . . 0.0 109.404 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.26 -49.27 77.78 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.246 179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 11' ' ' SER . . . -70.21 -22.96 77.57 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.118 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.643 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.07 -36.86 55.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.815 0.817 . . . . 0.0 110.19 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -47.26 27.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 114.081 -1.418 . . . . 0.0 109.194 -179.506 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.448 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.28 -20.83 65.7 Favored Glycine 0 N--CA 1.439 -1.155 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 177.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.558 ' HB2' ' O ' ' A' ' 7' ' ' GLY . 0.1 OUTLIER -73.57 -43.64 59.29 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -80.27 -29.08 38.26 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.624 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.493 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.9 OUTLIER -68.04 -51.98 40.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.17 0.51 . . . . 0.0 110.547 179.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.59 -19.84 78.89 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.61 -34.81 90.04 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.747 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.69 -34.27 52.93 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.272 0.558 . . . . 0.0 109.602 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.4 mt -69.89 -35.1 74.37 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.767 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.34 -60.9 2.14 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.183 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.81 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.62 120.31 10.93 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.825 -178.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 mt . . . . . 0 C--O 1.248 1.016 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.506 -179.423 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.833 HG23 HG23 ' A' ' 2' ' ' DIL . 15.1 tt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.614 0.245 . . . . 0.0 111.552 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.833 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.418 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 89.62 -97.93 2.38 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.655 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 11.7 Cg_exo -69.75 -18.13 37.24 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.27 1.98 . . . . 0.0 111.757 179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.0 t -85.11 -40.87 15.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.425 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.0 tp -56.48 -44.95 81.13 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.48 179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -69.82 -29.2 71.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.804 -0.713 . . . . 0.0 111.985 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.673 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.11 -39.6 48.9 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.857 0.837 . . . . 0.0 110.155 179.494 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.748 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.19 -49.16 23.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.196 -1.366 . . . . 0.0 109.467 -179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.44 -20.79 65.99 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 177.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.7 -46.44 65.98 Favored 'General case' 0 CA--C 1.522 -0.124 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.13 -31.11 30.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.64 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.748 HD12 HG13 ' A' ' 9' ' ' VAL . 55.4 mt -71.34 -51.21 25.51 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 121.062 0.458 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -60.61 -20.49 56.29 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -58.25 -33.97 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.248 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.41 -30.21 53.44 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 12.3 mt -71.95 -37.25 70.01 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.676 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.712 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.84 -0.45 53.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.071 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.581 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -25.8 67.91 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -178.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.712 ' N ' ' O ' ' A' ' 18' ' ' LYS . 2.1 mm . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.862 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.975 HG22 HG23 ' A' ' 2' ' ' DIL . 3.1 mp . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.766 0.317 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.975 HG23 HG22 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 76.72 -103.57 1.77 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.035 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.424 ' HD2' ' O ' ' A' ' 2' ' ' DIL . 8.8 Cg_exo -71.84 -2.62 11.75 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.452 2.101 . . . . 0.0 112.416 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG21 HG13 ' A' ' 2' ' ' DIL . 47.6 t -84.25 -37.46 12.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 CA-C-O 121.684 0.754 . . . . 0.0 108.991 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.3 tp -58.66 -48.77 79.92 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.381 -1.281 . . . . 0.0 110.491 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 11' ' ' SER . . . -70.53 -23.81 77.32 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.998 179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.638 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.96 -38.08 53.98 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.966 0.889 . . . . 0.0 109.923 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.458 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.77 -47.68 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.271 -179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -62.34 -21.23 61.9 Favored Glycine 0 N--CA 1.441 -1.001 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.543 ' HB3' ' O ' ' A' ' 7' ' ' GLY . 4.7 p -66.87 -48.22 69.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.21 -27.84 32.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.664 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 13' ' ' LEU . 0.4 OUTLIER -59.7 -51.52 69.43 Favored 'General case' 0 CA--C 1.518 -0.261 0 CA-C-O 121.133 0.492 . . . . 0.0 110.805 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -76.07 -19.81 78.22 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.59 -43.21 77.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.022 -0.609 . . . . 0.0 112.627 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 13' ' ' LEU . 1.8 pp -77.29 -37.46 52.73 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.49 0.662 . . . . 0.0 109.587 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 28.4 mt -54.16 -48.85 70.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.132 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -74.99 -35.56 62.04 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.285 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.828 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -66.74 140.5 57.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 121.519 0.676 . . . . 0.0 112.361 -178.511 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.716 -1.129 . . . . 0.0 111.628 -178.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.625 ' O ' ' HB ' ' A' ' 2' ' ' DIL . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.625 ' HB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 54.39 -109.74 1.31 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 120.564 -0.826 . . . . 0.0 112.298 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -85.16 8.33 4.67 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.66 2.24 . . . . 0.0 112.867 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.4 ' HA ' HD23 ' A' ' 8' ' ' LEU . 74.0 t -85.47 -38.62 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 CA-C-O 121.638 0.732 . . . . 0.0 109.531 179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.6 tp -60.41 -49.46 77.48 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.519 -1.218 . . . . 0.0 110.59 179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.441 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.94 -22.67 77.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.033 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.65 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.19 -38.51 56.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.853 0.835 . . . . 0.0 109.846 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.585 HG13 HD12 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.01 -47.87 26.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.052 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.46 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -66.42 -20.9 70.08 Favored Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 177.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -71.25 -43.34 67.45 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.15 -31.18 30.67 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.503 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.585 HD12 HG13 ' A' ' 9' ' ' VAL . 70.1 mt -70.79 -51.89 24.1 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-O 121.107 0.48 . . . . 0.0 110.533 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.45 -20.33 79.35 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.694 -0.963 . . . . 0.0 110.694 178.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -56.89 -44.16 92.41 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.626 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tt -77.16 -29.02 54.35 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.189 0.519 . . . . 0.0 109.633 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.47 -54.89 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.457 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.55 -56.2 9.11 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.837 179.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.798 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.99 124.27 20.66 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 121.46 0.647 . . . . 0.0 111.923 -178.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.25 1.101 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.604 -179.331 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.935 HG23 HG23 ' A' ' 2' ' ' DIL . 19.5 tt . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.569 0.223 . . . . 0.0 111.504 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.935 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 79.43 -102.05 1.93 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.0 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 4.7 Cg_exo -77.14 -0.18 10.34 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.596 2.197 . . . . 0.0 112.465 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.436 HG21 HG13 ' A' ' 2' ' ' DIL . 40.2 t -84.81 -40.08 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.716 0.77 . . . . 0.0 109.477 179.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.6 -49.26 76.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.531 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -68.4 -25.58 74.7 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.147 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.636 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.05 -39.39 50.15 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.846 0.832 . . . . 0.0 110.083 179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.25 -50.35 20.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.65 -179.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -63.45 -20.89 63.97 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 177.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.38 -49.02 63.09 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -24.12 34.21 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.054 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' VAL . 7.3 tp -56.86 -52.04 66.67 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.123 0.487 . . . . 0.0 110.82 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.42 -20.47 78.32 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.78 -28.94 73.43 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.348 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.23 -29.71 54.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -45.27 80.94 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.691 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -40.54 71.31 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.181 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.812 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -66.75 136.06 54.91 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 121.414 0.625 . . . . 0.0 112.127 -178.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 mt . . . . . 0 C--O 1.248 1.02 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.544 -179.225 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.754 HG23 HG23 ' A' ' 2' ' ' DIL . 6.6 tp . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.793 0.33 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.754 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 84.29 -101.5 2.44 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.65 -0.786 . . . . 0.0 111.597 -179.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 6.7 Cg_exo -72.46 -8.6 22.89 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.311 2.007 . . . . 0.0 111.922 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.444 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 38.6 t -84.46 -37.73 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 121.711 0.767 . . . . 0.0 109.161 178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.3 tp -55.94 -28.7 58.09 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 114.462 -1.244 . . . . 0.0 110.534 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.96 -35.49 30.83 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.832 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.62 -30.37 56.88 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.449 0.642 . . . . 0.0 110.482 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.757 ' O ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.02 -49.22 23.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.34 -179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.467 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -68.75 -20.89 74.61 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 177.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 m -78.51 -40.22 35.84 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 121.192 0.52 . . . . 0.0 109.6 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.08 -31.26 30.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.677 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 9' ' ' VAL . 3.5 mm? -65.85 -51.74 56.28 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.08 0.467 . . . . 0.0 110.541 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.42 -20.12 79.21 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -60.07 -46.23 94.56 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.773 -179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.5 -32.51 54.23 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.239 0.543 . . . . 0.0 109.609 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.9 mt -66.94 -44.41 80.7 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.708 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.76 -56.9 8.44 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.22 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.823 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.2 126.82 28.66 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 121.47 0.652 . . . . 0.0 112.045 -178.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.528 HG22 ' O ' ' A' ' 20' ' ' ILE . 6.7 mm . . . . . 0 C--O 1.248 1.011 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.474 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.874 HG23 HG23 ' A' ' 2' ' ' DIL . 7.7 tp . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.668 0.27 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.874 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -155.23 -62.03 0.01 OUTLIER Glycine 0 C--N 1.311 -0.839 0 CA-C-N 114.25 -1.341 . . . . 0.0 110.708 179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -84.57 -11.56 8.06 Favored 'Trans proline' 0 N--CA 1.451 -0.975 0 C-N-CA 123.199 2.599 . . . . 0.0 111.641 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.8 t -84.96 -39.16 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.672 0.749 . . . . 0.0 109.352 179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.57 -49.21 78.43 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.328 179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.405 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -69.0 -24.29 75.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.153 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.648 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.92 -39.54 50.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.874 0.845 . . . . 0.0 109.969 179.486 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.31 -48.84 23.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.412 -179.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.02 -20.68 67.11 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 177.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -69.93 -48.21 59.37 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 178.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.19 -25.47 34.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.841 179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 17.4 tp -56.59 -51.84 67.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.18 0.514 . . . . 0.0 110.536 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.6 -19.92 78.8 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.49 -18.46 79.84 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.689 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.18 -32.23 55.98 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 mt -69.96 -40.85 75.16 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.551 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HE2' ' HE3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -74.82 -18.1 60.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 179.798 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.826 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -69.9 142.88 52.91 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.501 0.667 . . . . 0.0 112.304 -178.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--O 1.249 1.054 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.609 -179.014 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.948 HG23 HG23 ' A' ' 2' ' ' DIL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.748 0.309 . . . . 0.0 111.232 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.948 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 92.68 -91.84 1.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.883 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 3.1 Cg_exo -79.88 2.21 8.6 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.718 2.279 . . . . 0.0 112.172 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' A' ' 6' ' ' LEU . 0.3 OUTLIER -83.97 -40.72 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.846 0.831 . . . . 0.0 108.823 178.922 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' N ' ' CG1' ' A' ' 5' ' ' VAL . 48.8 tp -53.58 -49.1 68.47 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.442 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.83 -25.93 74.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.125 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.667 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -77.0 -38.61 52.77 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.827 0.823 . . . . 0.0 109.976 179.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.28 -49.32 22.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.414 -179.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -65.51 -20.83 68.24 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 177.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.21 -49.6 63.94 Favored 'General case' 0 CA--C 1.521 -0.157 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.26 -23.98 35.01 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.709 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.5 tp -55.05 -51.99 64.6 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-O 121.145 0.498 . . . . 0.0 110.633 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.56 78.09 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 110.695 -0.962 . . . . 0.0 110.695 178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -75.76 -19.94 78.55 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.549 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 tt -77.04 -31.68 56.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -67.02 -36.64 82.55 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.345 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -57.62 3.95 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.078 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.808 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.08 129.93 42.46 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 121.45 0.643 . . . . 0.0 112.033 -178.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.249 1.066 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.528 -179.364 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.491 HD13 ' N ' ' A' ' 1' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.419 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.452 ' CB ' ' O ' ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 52.86 -104.47 0.19 Allowed Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.56 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.417 ' O ' HD21 ' A' ' 8' ' ' LEU . 18.5 Cg_exo -65.86 -8.33 19.4 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.431 2.087 . . . . 0.0 112.651 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.446 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 37.2 t -84.2 -36.0 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.624 0.726 . . . . 0.0 109.136 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.4 tp -58.13 -29.81 65.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.532 -1.213 . . . . 0.0 110.611 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -77.28 -32.4 48.08 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.794 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -76.38 -31.33 57.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.499 0.666 . . . . 0.0 110.169 179.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.13 -49.5 22.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.17 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.468 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -69.78 -21.26 76.48 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.0 t -64.55 -46.57 82.25 Favored 'General case' 0 CA--C 1.52 -0.184 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.25 -28.16 32.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.418 178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 13' ' ' LEU . 4.2 tt -60.64 -51.76 68.04 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.136 0.493 . . . . 0.0 110.604 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.58 -20.5 73.91 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.23 -50.81 63.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.4 -29.56 53.18 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.205 0.526 . . . . 0.0 109.795 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.55 -50.89 71.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.714 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.413 ' O ' ' CE ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -75.63 -56.09 5.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.883 179.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.81 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -63.3 137.82 58.32 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.43 0.633 . . . . 0.0 111.927 -178.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.249 1.038 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.583 -178.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.922 HG23 HG23 ' A' ' 2' ' ' DIL . 6.1 tp . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.922 HG23 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.452 ' HA3' ' HD3' ' A' ' 4' ' ' PRO . . . 85.03 -99.08 2.29 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.921 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.452 ' HD3' ' HA3' ' A' ' 3' ' ' GLY . 2.6 Cg_exo -75.41 -3.7 14.27 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.509 2.139 . . . . 0.0 112.206 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -84.47 -37.24 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 CA-C-O 121.686 0.755 . . . . 0.0 109.21 178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 tp -58.27 -49.07 78.44 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.223 179.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.401 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -68.58 -25.25 75.07 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.047 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.64 ' O ' HD12 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -76.98 -39.97 48.49 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.824 0.821 . . . . 0.0 109.973 179.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.4 OUTLIER -77.27 -49.05 23.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.446 -179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -64.71 -20.76 66.55 Favored Glycine 0 N--CA 1.441 -0.996 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 177.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.401 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 0.4 OUTLIER -67.84 -49.14 63.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.1 -25.12 34.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.731 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -56.77 -51.81 67.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.177 0.513 . . . . 0.0 110.704 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.33 -20.21 79.84 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.86 -38.54 75.76 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.493 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.29 -29.25 53.65 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.268 0.556 . . . . 0.0 109.679 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -55.9 22.48 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.731 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -53.37 35.19 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.068 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.808 ' HA ' ' CE ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -62.75 126.24 26.66 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 121.454 0.645 . . . . 0.0 112.017 -178.673 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm . . . . . 0 C--O 1.25 1.085 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.535 -179.489 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.564 HG23 HG12 ' A' ' 2' ' ' DIL . 2.5 tt . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.681 0.277 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' DIL . . . . . 0.564 HG12 HG23 ' A' ' 1' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 149.93 -67.18 0.36 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 113.886 -1.507 . . . . 0.0 110.948 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.451 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 1.2 Cg_endo -83.07 -10.78 10.15 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.077 2.518 . . . . 0.0 111.704 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.9 t -84.22 -37.89 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 CA-C-O 121.671 0.748 . . . . 0.0 109.052 178.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.3 tp -55.14 -28.38 52.32 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.403 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.407 ' O ' ' CB ' ' A' ' 11' ' ' SER . . . -79.12 -37.83 24.03 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 4' ' ' PRO . 0.3 OUTLIER -76.78 -32.55 57.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.34 0.59 . . . . 0.0 110.424 179.54 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.68 ' O ' HD13 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -77.43 -50.53 20.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.397 -179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . -67.29 -20.88 71.75 Favored Glycine 0 N--CA 1.441 -0.981 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.407 ' CB ' ' O ' ' A' ' 7' ' ' GLY . 3.3 t -69.68 -46.42 66.09 Favored 'General case' 0 CA--C 1.52 -0.182 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.5 -32.5 28.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.893 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 9' ' ' VAL . 10.1 mp -73.17 -52.19 15.06 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.076 0.465 . . . . 0.0 110.883 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.05 -20.39 74.71 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.55 -56.65 20.29 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.606 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.1 mp -77.58 -26.02 50.44 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.007 0.432 . . . . 0.0 109.99 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.639 HD13 ' O ' ' A' ' 17' ' ' LEU . 2.5 tm? -70.82 -43.12 69.25 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.016 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.754 ' O ' ' N ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -84.54 -1.08 55.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.072 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -26.64 65.09 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -179.015 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.754 ' N ' ' O ' ' A' ' 18' ' ' LYS . 1.1 mm . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.847 179.241 . . . . . . . . 1 1 . 1 stop_ save_